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Mycoplasmal pneumonia of swine (MPS) is a chronic respiratory 
disease of pigs characterized by a nonproductive cough, retarded growth 
and poor feed utilization. The etiological agent of the disease is 
Mycoplasma hyopneumoniae (syn. Mycoplasma suipneumoniae) (1,2). The 
disease has a worldwide distribution and is an important economic burden 
on the swine industry, especially in countries with intensive rearing 
practices. Serological studies have revealed that antibodies to M. hyo­
pneumoniae were present in 60% of Iowa swine herds (3)• Lesions similar 
to those of MPS have been found in 45% to 75% of slaughtered pigs (4,5). 
Attempts to control MPS by inducing immunity to M. hyopneumoniae have 
given positive (6,7,8,9,10,11) and negative (12,13,14) results. Both cell-
mediated and humoral immune responses to the organism developed following 
vaccination (13,14) and experimental infection (15), but the exact roles 
of these immune responses in protection or pathogenesis of MPS have not 
been determined. Studies conducted in other animal species with myco­
plasmal pneumonias similar to MPS indicated that the local humoral response 
was important in control of the disease (16,17,18,19). 
Apart from the presence of glycocalyx-like material on the surface of 
virulent M. hyopneumoniae (20) and the ^  vitro cytopathic effect ex­
hibited by M. hyopneumoniae membranes (21) no other pathogenicity factor 
has been associated with M. hyopneumoniae. Various nonspecific inter­
actions between mycoplasmas and lymphocytes have been reported and their 
possible roles as factors in development of lesions in mycoplasmal 
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diseases investigated (22,23,24,25,26,27). 
In an effort to help elucidate the pathogenesis of MPS, the following 
approach was taken to study interactions between M. hyopneumonlae and the 
porcine immune system; i) the nonspecific mitogenic activity of M. hyo­
pneumonlae membranes for swine lymphocytes was evaluated; ii) membrane 
preparations of M. hyopneumoniae given intratracheally to pigs were tested 
for their ability to either induce lesions of pneumonia similar to those 
seen in natural cases of MPS, or to induce some protection against subse­
quent challenge with live M. hyopneumoniae; iii) the systemic and local 
humoral and cell-mediated immune responses of pigs following experimental 
infection with M. hyopneumoniae were monitored in order to compare them with 
the effects of M. hyopneumoniae membranes on the immune system. 
This dissertation was written in the alternate format. It consists of a 
general introduction, a review of the literature, three separate manuscripts, 
and a general discussion. The references cited in the introduction, liter­
ature review, and the general conclusion are listed following the general 
discussion. Each separate manuscript is written according to the guidelines 
of the American Journal of Veterinary Research. A list of references cited 
in each manuscript follows the manuscript. The doctoral candidate. Serge 
Messier, was the principal investigator and is the senior author of each 




The peribronchiolar and perivascular lymphoid hyperplasia observed 
in microscopic lesions of MPS and other similar nycoplasmal pneumonias 
occurring in various animal species strongly suggests that the immune system 
is involved in the development of lesions. This involvement may lead to 
the mounting of a specific immune response, cell-mediated, humoral, or 
both, against the organism involved. The mycoplasmas have evolved various 
virulence factors that may facilitate colonization of the respiratory 
tract. The motility (28) and attachment properties (29,30,31) of Mycoplasma 
pneumoniae, Mycoplasma pulmonis, and Mycoplasma gallisepticum could help 
these organisms penetrate the mucus layer covering the bronchial epithelium 
and allow them to attach to the epithelial cells. Ciliostatic effects 
observed ^  vitro in tracheal organ cultures infected with M. pneumoniae 
(32), Mycoplasma dispar (33), or M. pulmonis (34) would be an important 
virulence factor if expressed ^  vivo. A cytopathic effect was produced 
in cell cultures by Mycoplasma bovis (35) and Mycoplasma hyopneumoniae (21) 
but the mechanism leading to cell damage is unknown. Hemolysins are 
produced by many mycoplasmas and in some cases the hemolysin has been found 
to be hydrogen peroxide; the in vivo role of these cell products is still 
obscure (36). The presence of glycocalyx-like material has been demon­
strated on M. dispar (37), M. pulmonis (30), and M. hyopneumoniae (20) 
by ruthenium red staining. The role of capsular substance as an anti­
phagocytic virulence factor in bacteria is very well-documented. Develop­
ment of autoantibodies against red blood cells (cold agglutinin), nervous 
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and cardiac tissues following H* pneumoniae infection has been linked to 
similarities in membrane components of the mycoplasma and host tissues 
(38,39). These similar componenLs may permit escape from the immune 
response or induce autoimmune diseases. 
In the absence of specific antibodies, mycoplasmas can survive quite 
well in cultures of alveolar macrophages (40,41,42,43), as well as in the 
presence of neutrophils (41,44) but addition of specific antisera will lead 
to ingestion of the mycoplasmas. This ability to survive could well be 
of importance in establishment of infection in unsensitized animals. 
Mycoplasmas have been found to interact nonspecifically with lympho­
cytes and induce several responses. The nonspecific interactions, or their 
consequences, between mycoplasmas and lymphocytes might modulate the immune 
system in such a way that it results in development of lesions. It is quite 
possible also that both specific and nonspecific interactions between 
mycoplasmas and the immune system are involved in the development of lesions. 
Mycoplasma-Lymphocyte Interactions 
Mitogenic activity of mycoplasmas 
Ginsburg and Nicolet (22) reported in 1973 that a mycoplasma species, 
M. pulmonis, induced blastogenesis of rat lymphocytes ^  vitro. The 
transforming activity of the mycoplasmas was believed to be nonspecific. 
Additionally, the transformation factor was found to be heat labile (56°C, 
30 minutes), and was associated with the organisms because it was lost 
after filtration of the culture fluid. Growth of the mycoplasmas in the 
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lymphocyte cultures was necessary for the transforming activity to be 
expressed. 
Following this report, numerous species of Mycoplasma were tested in 
order to determine if they possessed mitogenic properties. M. pneumoniae 
was found to be mitogenic for mouse (24,45), guinea pig (24), and human 
lymphocytes (46). Rat (47,48,49) and mouse (45,47) lymphocytes were 
stimulated by M. pulmonis ; Mycoplasma neurolyticum could also stimulate 
lymphocytes of rat (48,50) and mouse (47,51) origin. Mycoplasma arthritidis 
induced transformation of lymphocytes obtained from rats (48,52,53) and 
humans (52,54). Acholeplasma laidlawii was found to stimulate murine 
lymphocytes (45,55). Mycoplasma fermentans was mitogenic for mouse (45) 
as well as human (46) lymphocytes. Other species reported to have mitogenic , 
activity for mouse lymphocytes included: Mycoplasma canis, Mycoplasma felis, 
M. gallisepticum. Mycoplasma synoviae. Mycoplasma hyorhinis, Spiroplasma 
citri. Mycoplasma sp. GS-1, Mycoplasma hyosynoviae. Mycoplasma hominis, 
and Mycoplasma arginini (45). 
The mitogenic activity exhibited by the numerous mycoplasma species 
mentioned was associated with live mycoplasmas (48), nonviable organisms 
(45,55), suspensions of disrupted organisms obtained by ultrasonication 
(24,45,46) or by osmotic lysis (47,48,49,50,51), and culture supemate (52, 
53,54). Membrane preparations of mycoplasmas were found to stimulate 
lymphocytes to the same extent as live cultures of the organisms (48). 
Either T- or B-lymphocytes or both are stimulated by mycoplasmas 
indicating heterogeneity exists in mitogenic activity produced by the 
various mycoplasmas species. Guinea pig (24) and human (46) T- and 
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B-lymphocytes were both activated by M. pneumoniae. Stimulation of T-
and B-lymphocytes also occurred ^ en cell preparations of rat and mouse 
origin were exposed to M. pulmonis (47,49). Activation of human T- and 
B-lymphocytes by M. fermentans was also reported (46). Selective 
stimulation of B-lymphocytes was noted in rat and mouse cells exposed to 
M. neurolyticum (47,50,51), and in mouse lymphocytes stimulated by 
A. laidlawii (45,55). On the other hand, human and murine T-lymphocytes 
were stimulated by M. arthrltidis (53,54). 
Heat—treatment of the various mitogens, at 56®C for periods of time 
ranging from 0.5 to 2 hours, resulted in loss of the mitogenic activity 
(53,54,56), no alteration of the mitogenic activity (24,45,46), or 
expression of heat-resistant mitogen following inactivation of an in­
hibitory factor (45). The nature of this inhibitory factor v>s not further 
documented. 
The mitogenic activity exhibited by the mycoplasma species mentioned 
previously was found to result from nonspecific stimulation of lymphocytes 
and meant that the positive response was not dependent on previous sensi­
tization to antigen. This was confirmed by using experimental subjects 
without serological evidence of previous infection caused by the mycoplasma 
species tested (22,45,46,52,53) or specific-pathogen free animals (24,47, 
48,49,50,51,53) and getting positive stimulation. On the other hand, 
activation of human lymphocytes by A. laidlawii could not be ruled out as 
antigen specific stimulation because the immune status of the individuals 
tested was unknown (55). 
Some responses of the immune system to stimulation are known to be 
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under control of genes encoded within the major histocompatibility complex 
(MHC) (57). Regulation by the MHC was believed to occur in the response of 
murine (53) and human (54) lymphocytes to stimulation by M. arthritidis» 
as well as in the transformation of murine splenic lymphocytes by M. 
hyorhinis (58). Differences noted in susceptibility of 2 different strains 
of rats to M. pulmonis infection, or lymphocyte responsiveness to stimula­
tion by M. pulmonis were not explained (59,60,61). Although a genetic 
mechanism probably regulated the strain susceptibility noted, dissimilarity 
in number of T-helper lymphocytes was mentioned as a factor that might 
influence differences in susceptibility to disease (62). 
The biochemical composition of the mitogenic factor(s) associated with 
the various mycoplasma species mentioned above is in most cases not well-
defined. It was clearly demonstrated (56) that the mitogen present in 
membrane preparations of M. pulmonis was proteinaceous in nature, and 
exposed on the outer surface of the membrane. Recent data (47), indicated 
that carbohydrate-containing membrane components of M. pulmonis might also 
be involved in the mitogenic activity. In the same study (47) it was 
reported that M. neurolyticum mitogen was present in the membrane of the 
organism and composed mainly of substances containing carbohydrates. 
Membrane proteins and lipids were also found to have some mitogenic activity. 
Indirect evidence suggests that the mitogen present in culture supemate of 
M. arthritidis is protein or contains protein, since heating the supemate 
at 56°C for 60 minutes abrogated the mitogenic effect (53,54). Seat-resis­
tance of mitogens from M. pneumoniae (24,46), M. fermentans (46), 
A. laidlawii (55), M. hyosynoviae (45), M. hominis (45), 
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and M. arglnlni (45) ^ dicates that proteins are not present, or are 
unimportant in the make-up of the mitogenic factors of these species. 
Evidence that the stimulatory effect of mycoplasma mitogen observed 
in vitro correlates with involvement of the mitogen in the pathogenesis of 
the corresponding disease has been reported only for M. pulmonis. Rats 
inoculated intranasally with membrane preparations of M. pulmonis, known to 
be mitogenic for rat lymphocytes, developed tracheitis and interstitial 
pneumonia (63). Lung lesions were similar to those developing during active 
infection with the organism and initially consisted of alveolar thickening 
and edema, interstitial infiltration of lymphocytes, macrophages, and plasma 
cells; followed by peribronchiolar and perivascular lymphocytic cuffing and 
lymphocytic nodule formation. It was thus concluded that mitogenicity of 
M. pulmonis contributed to production of pneumonia in rats. 
The identical nature of the mitogenic factor(s) and the lesion inducing 
factor(s) has not been proven. But, decrease in the lesion inducing 
capacity (63), and mitogenic activity (56) of M. pulmonis following heat-
treatment or proteolysis of menibrane preparations would suggest that they 
are related. 
Polyclonal activation of antibody production 
In addition to inducing blastogenesis, measurable by incorporation of 
radioactive nucleotide or enumeration of blast cells, a few mycoplasma 
species have also been found to induce polyclonal antibody production, 
resulting from the transformation of B-lymphocytes into plasma cells. 
The transformation of B-lymphocytes into antibody producing cells occurred 
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with (24,46,49,50) and without (64) synthesis of DNA. Detection of antibody 
producing cells, done by a modified haemolytic plaque assay, revealed that 
lymphocytes isolated from various anatomical sites or animal species were 
induced by M. pneumoniae (24,64), M. fermentans (46), M. pulmonis (49), 
and M. neurolyticum (50). Also reported was the fact that human lymphocytes 
exposed to killed suspensions of M. pneumoniae started producing antibodies 
to measles, rubella, and/or herpes simplex virus (65). The phenomenom was 
believed to be T-cell dependent and probably resulted from the release of 
nonspecific helper factors by M. pneumoniae stimulated cells. 
Mycoplasma capping by lymphocytes 
In studies of murine lymphocytes culture infected with M. hyorhinis 
the organism has been found to selectively acquire host cell membrane 
antigens (23). Association of M. hyorhlnis with the surface of cells was 
demonstrated by complement-dependent cytotoxicity (23), and by immuno­
fluorescence assays (66). Mycoplasma hyorhinis acquired host-membrane 
antigens following capping and shedding from the surface of the lymphocytes 
(23,66,67,68). Host antigens identified on the surface of M. hyorhinis 
Ic 
after infection of lymphocytes included Thy-1 antigen (23,67,69), H-2 
antigen (23,67), but not gp70 antigen (67). The possibility that some 
antigens act as receptors for M. hyorhinis was mentioned (23). Thy-1 
bearing cells were noted to be heavily infected by M. hyorhinis after 
24 hours while cells not possessing Thy-1 antigen were only lightly infected 
after 72 hours (58). 
Capping of mycoplasmas from lymphocytes generally led to blast 
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transformation in these cells (58,66,68). The consequences of non­
specific stimulation of lymphocytes would depend on the type and sub-
population of lymphocytes activated. 
Besides capping of host cell antigen, translocation of lipid molecules 
from the host membrane to M. hyorhinis could be demonstrated (69). Both 
capping and translocation of host molecules to mycoplasmas might induce 
modifications In the composition and conformation of the host membrane 
and possibly lead to immunopathologic disease. Another possible mechanism 
leading to Immunopathologic manifestations could be the presentation of 
modified host membrane antigens to the immune system which recognizes them 
as foreign. 
Induction of Interferon production 
The first successful ^  vitro Induction of Interferon production by 
mycoplasmas was obtained ^ en ovine leukocytes growing in mixed culture 
with fetal lamb kidney cells produced substantial levels of Interferon, 
which were attributed to infection of the kidney cells by A. laldlawii (25). 
Eleven other species of mycoplasmas were also capable of Inducing inter­
feron production in ovine leukocyte cultures (70). Live organisms were 
required for interferon production to occur (25,70). 
Interferon was produced by ovine lymphocytes, but not by polymor­
phonuclear cells (PMN), following ^  vitro exposure to M. pneumoniae, 
A. laldlawii, M. arthritidis, and M. pulmonis (71); it was also found that 
human lymphocytes produced interferon following exposure to M. pneumoniae 
(71,72) and M. synovlae (71). Interferon production was not detected in 
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murine peripheral leukocyte, spleen cell, and peritoneal cell cultures 
infected with A. laidlawii, M. pneumoniae, or M. arthritidis (73); but 
M. argiTiini was found to cause interferon production in murine spleen cell 
cultures and the data suggested that interferon was produced by B-lympho-
cytes (74). Human tumor cell lines known to be producing interferon 
stopped doing so as soon as they were rid of a Mycoplasma orale 1 infection 
(75). Reinfection of the cell lines with the same organism restored inter­
feron production. 
Peak-serum levels of interferon were detected 6 hours following intra­
peritoneal injections of mice with A. laidlawii, M. pneumoniae, or M. 
arthritidis (73); but other investigators (72) failed to do so after intra­
peritoneal inoculation of M. pneumoniae• 
The potency of mycoplasmas as an interferon inducer vitro was found 
to be less than that of bluetongue virus (25,70,71), but comparable to that 
of Newcastle disease virus (72). ^ vivo studies revealed that Newcastle 
disease virus was a more potent interferon inducer than M. arthritidis (73). 
Interferon induced by mycoplasmas has had no deleterious effect on 
the organisms (25,70,72), and in fact growth of the mycoplasmas, up to 
optimal levels, generally resulted in increasing titers of interferon 
(25,70). 
Cole and Thorpe (76) have indicated that, according to the character­
istics of the interferon produced in early studies (25,70,71,72,73,74,75) 
it was most probably interferon a. Mitogen(s) present in culture supemate 
of M. arthritidis induced human lymphocytes to produce interferon y (76); 
while hydrogen peroxide released by M. pneumoniae cocultured with human 
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lymphocytes was responsible for production of B and y interferon (77). 
Other responses 
Recently, new evidence of interaction between mycoplasmas and lympho­
cytes has been presented. It was found that rat lymph node lymphocytes 
stimulated by M. pulmonis membranes produced significant levels of inter-
leukin-2 (IL-2), while M. neurolyticum stimulated cultures contained 
negligible amounts of IL-2 (27). IL-2 is produced by T-lymphocytes following 
antigen specific interaction, or stimulation by a T-cell mitogen such as 
concanavalin A (78), and is required for the continued growth of activated 
T-cells (79,80). It seems possible then that a nonspecific helper factor 
released by M. pneumoniae stimulated T-cells (65), inducing polyclonal 
activation of human blood lymphocytes, was in fact some type of interleukin. 
Evidence of yet another aspect of mycoplasma-lymphocyte interaction 
was provided when it was demonstrated that viable M. arthritidis and M. 
hominis induced normal mouse lymphocytes to become cytotoxic for allogeneic 
and syngeneic mouse embryo fibroblasts (26). These findings led to the 
suggestion that such activation of lymphocytes vivo could result in cell 
damage and initiate an inflammatory reaction. 
Humoral Immunity 
The majority of studies dealing with the local response of various 
animal species to the respective mycoplasmal pneumonia has documented 
mainly the humoral response (16,18,81,82,83,84,85,86). Mycoplasma hyo-
pneumoniae is considered a porcine respiratory tract pathogen (36) and 
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conceivably, local immunity would be of importance in response of the host 
to this aggression. 
The humoral immune response of pigs to infection by H. hyopneumoniae 
has generally been evaluated using level of serum antibodies. These anti­
bodies can be detected by the complement-fixation test (CF) (87,88), 
indirect hemagglutination test (IHA) (83,89,90), tube agglutination test 
(91,92), and enzyme-linked immunosorbent assay (ELISA) (93). Comparative 
studies indicated that thex^ was a good correlation between results obtained 
with CF and ELISA tests (94), and the CF, ELISA, and IHA tests (95,96). 
Differences in test sensitivity were noted. 
Antibodies in lungs 
Natural or experimental respiratory mycoplasmal infections of various 
animal species have elicited development of local antibodies to these 
organisms. Antibodies were detected in bronchial (81), nasal (16), and 
tracheobronchial secretions (82,97,98,99), sputum (16), and lung washings 
(18,86). The predominant class of antibodies present was IgA (16,81,82, 
86,97). Antibodies of the IgM (81,82) and IgG (16,81,82,86) classes were 
also detected. 
Presence of local antibodies correlated better than systemic antibodies 
with resistance to M. pneumoniae (16,17), M. bovis (18,100) or M. pulmonis 
Infection (19). Furthermore, studies on M. pulmonis infection in mice 
indicated that antibodies of any immunoglobulin isotype could mediate 
resistance to the infection (101). However, in the case of pulmonary 
disease due to M. pneumoniae, the organism could be isolated from sputum 
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specimens of more than 50% of the patients even if these specimens contained 
specific antibodies (102). 
Antibodies to M. hyopneumoniae were found in lung and bronchial lymph 
node extracts (83), and in tracheobronchial secretions (84,85) of infected 
pigs. Antibodies could be detected by IHA in tracheobronchial secretions 
but not in serum of pigs killed 2 and 4 weeks post-infection, and were 
tentatively identified as secretory IgA (84). Use of the ELISA allowed 
antibodies of the IgM, IgG, and IgA classes, specific for M. hyopneumoniae, 
to be detected in tracheobronchial secretions by 2 weeks post-infection 
(85). Maximal values were attained by 5 weeks post-infection for both IgM 
and IgG antibodies in tracheobronchial secretions; titers of IgA antibodies 
increased over the 8 week period of the experiment (85). Titers of anti­
bodies in sera, due exclusively to the IgG isotype, reached a maximum at 
7 weeks post-infection (85). Tracheobronchial secretions collected 13 weeks 
post-infection contained IHA antibodies of both IgA and IgG classes, but 
IgG antibodies were thought to be serum antibodies transuded into the 
airways (84). 
Preferential involvement of the local response over the systemic 
response following infection of pigs with M. hyopneumoniae has been suggested 
when it was found that the percentage and total number of B-lymphocytes 
in lungs increased following infection (103). Percentage of B-lymphocytes 
in peripheral blood did not vary following infection. 
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Antibody producing cells in lungs 
Direct visualization of imnmnoglobulin-bearing cells in lesions of 
respiratory mycoplasmal infection has been done by indirect immunofluores­
cence (82,104,105) and by the avidin-biotin technique (85). Peribronchiolar 
lymphoid hyperplasia in lungs of hamsters infected with M. pneumoniae 
consisted mainly of IgM-positive cells; detection of IgG-positive cells 
varied throughout the experiment and number of IgA-positive cells was 
minimal (105). In mice infected with M. pulmonis, IgM-positive cells 
appeared early in the perivascular and peribronchiolar spaces and were 
followed within a week by IgG- and IgA-positive cells. Cells of this latter 
isotype predominated by 3 weeks post-infection and remained so until the 
end of the experiment (82). Characterization of lymphocyte populations in 
lungs of rats infected with M. pulmonis revealed that the only population 
of immunoglobulin-bearing cells to increase in the F344 strain were those 
of the IgA isotype (99,106), whereas in LEW rat strain all B-cell isotypes 
were increased significantly (99). During the first 2 weeks post-infection, 
pigs infected with M. hyopneumoniae had minimal stimulation of immuno-
globulin-containing cells in the lungs; but by 3 weeks post-infection, IgA-
and IgG-positive cells had increased 20 times and a rapid decrease in number 
of immunoglobulin-positive cells occurred at 5 weeks post-infection (85). 
The number of cells producing antibodies specific for the antigen involved 
were estimated to be about 1% of the total number of immunoglobulin-positive 
cells present in the lung in the case of M. hyopneumoniae (85), and for 
M. pulmonis between 50 to 80% of the plasma cells in the lungs (82). The 
number of plasma cells of each immunoglobulin class, IgM, IgG, and IgA, 
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increased as a consequence of M. pulmonis infection in the rat (99). Other 
investigators (104) reported that plasma cells were not detected by histo­
pathologic examination in lungs of mice infected with M. pulmonis. When 
hamsters having recovered from M. pneumoniae infection were rechallenged 
with the same strain of organism and their lungs examined for immunoglobulin-
positive cells, it was found that only a few IgA-positive cells were present. 
The bulk of lymphocytes in the peribronchiolar and perivascular areas were 
nonimmunoglobulin producing cells (105). 
Changes taking place in paratracheal lymph nodes of mice infected 
with M. pulmonis (82), and in bronchial lymph nodes of pigs infected with 
M. hyopneumoniae (85) were generally similar. Increased numbers of immuno-
globulin-containing cells of all classes were noted 2 weeks post-infection 
and lasted for about 3 to 4 weeks. Following this period, the number of 
plasma cells gradually diminished. 
Cell-Mediated Immunity 
Clear evidence of the pathogenic or protective roles for cell-mediated 
immunity (CMI) in mycoplasmal respiratory infections have not yet been demon­
strated. Increase in number of T-lymphocytes in lungs following infection 
of rats with M. pulmonis has been reported (99,106) but no functional 
analysis of these lymphocytes was done. Investigators have used indirect 
methods to study the role of CMI in the lungs. 
Suppression of CMI has been the most common method used to study its 
roles in various processes. Immunosuppression has been achieved by 
thymectomy (104,107), administration of drugs (108), or antithymocyte 
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serum (107,109,110). 
Animals inmninosuppressed and subsequently infected with mycoplasma 
species known to cause pneumonia have developed less severe microscopic 
lesions of pneumonia than nonimmunosuppressed infected animals. This 
phenomenom was observed in mice infected with M. pulmonis (104), hamsters 
infected with M. pneumoniae (109,110), and pigs infected with M. hyo-
pneumoniae (107). Â consistent finding in immunosuppressed infected 
animals was the marked reduction in the number of lymphocytes around 
bronchioles and blood vessels (104,107,109,110). Bronchiolar and alveolar 
exudate of immunosuppressed infected hamsters (109,110) and pigs (107) 
consisted mainly of macrophages with little PMN infiltration, whereas the 
exudate found in Immunologically normal infected animals consisted pre­
dominantly of PMNs. Immunosuppressed mice infected with M. pulmonis (104) 
had fewer alveolar macrophages in the exudate than infected control mice 
and no apparent difference in PMN numbers was noted. 
Although immunosuppression reduced the severity of pneumonia, it did 
allow mycoplasmas to multiply and reach titers 10 to 1000 times higher in 
the lungs (104,107,108,110). Another consequence of immunosuppression was 
that dissemination of mycoplasmas from the lungs to other organs (liver, 
spleen, and brain) occurred at least twice as frequently as in immuno­
competent mice (104), and titers of mycoplasmas in these organs were 
consistently higher (108). Immunosuppression induced by a combination of 
cyclophosphamide treatment and M. pulmonis infection of mice resulted in 
greater mortality rate than could be accounted for by M; pulmonis or 
cyclophosphamide treatment alone (108). 
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Reconstitution with spleen cells from mice previously infected with 
H. pulmonis significantly decreased mortality rate in mice immunosuppressed 
with cyclophosphamide and infected with M. pulmonis (108). However, transfer 
of spleen cells from immune to nonimmune recipient mice did not confer 
protection against H. pulmonis pneumonia (111). The ability of spleen cells 
to confer immunity in the respiratory tract was questioned by the authors 
and appears unlikely in light of what is known today about cell migration 
at mucosal surfaces. In a recent review (112), apparent extensive traffic 
of immunocompetent cells between secretory sites was cited as support for 
the existence of a mucosal-associated lymphoid tissue (MALT). Tissues and 
organs involved included the gut, lungs, mammary glands, salivary and 
lacrimal glands, and possibly the urinary and genital tracts. 
Because systemic CMI is easier to evaluate, it has generally been 
the way by which possible CMI to respiratory mycoplasmal infection has been 
assessed. Exposure of peripheral blood lymphocytes (PBL) to antigen and 
measurement of the incorporation of radiolabeled nucleotide has been the 
most widely used procedure. The majority of early published reports dealt 
with M. pneumoniae infections in humans (113,114,115,116). Sensitized 
PBL were generally detected within a month following onset of disease and 
persisted for several years. Recent or active infection with M. pneumoniae 
in children was found to be better indicated by the response of lymphocytes 
from adenoid vegetations than PBL (117). This observation added support 
to the suggestion that repeated asymptomatic infections due to M. pneumoniae 
resulted in increasing numbers of locally sensitized lymphocytes reaching 
the systemic circulation, as evidenced by the fact that as the age of the 
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patients increased so did their stimulatory response to M. pneumoniae 
antigens (118). In a guinea pig model used to study M. pneumoniae infection, 
sensitized spleen cells were detectable 2 weeks after infection and remained 
so up to 6 weeks post-infection; these responses were taken as an indication 
of CMI (97). 
Detection of positive stimulation of PBL from pigs infected with 
M. hyopneumoniae was first noted from one week post-exposure (14) up to 
15 weeks post-infection (15), and remained detectable up to 44 weeks post­
infection (15). Vaccination of pigs with killed M. hyopneumoniae induced 
the appearance of sensitized PBL 3 to 4 weeks after the first immunization 
(13,14). Infection of vaccinated pigs with M. hyopneumoniae resulted in 
marked increases in the lymphocyte stimulation index of PBL (13,14). 
Although histological examination of bronchial lymph nodes from pigs 
infected with M. hyopneumoniae revealed cell proliferation in the thymus-
dependent area (107,119) lymphocytes isolated from bronchial lymph nodes 
of vaccinated challenged pigs were not stimulated by M. hyopneumoniae 
antigens (14). The fact that hyperplasia of germinal centers was also 
observed in Infected pigs (107,119) might suggest that local proliferation 
of antibody-producing cells (85) is more important than cell-mediated 
immunity. Systemic CMI to M. hyopneumoniae has been associated with the 
recovering stage of mycoplasmal pneumonia (15), but Increased CMI Induced 
by vaccination could not be correlated with protective activity (14), or 
reduction in gross lesions of pneumonia (13). 
The leukocyte migration inhibition test was found useful for detection 
of CMI to M. pneumoniae (120), Mycoplasma mycoides var. mycoides (121), 
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and M. hyopneumoniae (122,123), but was judged less sensitive than the 
lymphocyte stimulation test (120,121,123). Intradermal allergic reaction 
to mycoplasmal antigens has also been used to study CMI in cattle (121, 
124), guinea pigs (97), and pigs (15,123), and was also found less sensitive 
than the lymphocyte stimulation test (15,121,123). 
Immunosuppression 
The lengthy course of various mycoplasmal diseases, respiratory 
infections included, has prompted the suggestion that mycoplasmas might 
have an immunosuppressive effect on their host. This would occur even in 
presence of. developing systemic and local immunity. 
Simultaneous injections of M. arthritidis and viral (125) or bacterial 
antigens (126) resulted in complete or partial suppression of the humoral 
response to the antigens. However, injection of mycoplasmas 10 days after 
immunization with the viral antigen did not affect the antibody response 
(125). Both viable cells (126) and membrane preparations (125) of M. 
arthritidis could exert the suppressive effect on the humoral response. 
Mycoplasma pneumoniae also appeared to have some effect on humoral immunity 
vtiea a transitory depression of serum IgG was noted in patients with 
pneumonia caused by this organism (127). 
Several investigators reported that following infection with mycoplasmas 
there was depression of CMI. This depression was detected in vitro by loss 
of responsiveness by lymphocytes to stimulation by the mitogen PHA (121, 
124,125,127,128), or by purified protein derivative (PPD) of Mycobacterium 
tuberculosis (129). Inhibition of the mitogenic effect of PHA or PPD was 
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variable, ranging from partial to complete (121,124,125,127,129). 
Decrease in uptake of radiolabeled nucleotide by nonstimulated lymphocytes 
vas also noted (121). Attempts to induce responsiveness, by lymphocytes, 
to the specific antigen during the period of depressed CMI yielded negative 
results (121). Additionally, transient anergy to tuberculin, noted early 
after onset of pneumonia associated with M. pneumoniae, was thought to 
reflect possible depression of CMI (102,129,130). Major reduction in the 
percentage of blood T-lymphocytes has been recorded in a patient suffering 
from acute mycoplasmal pneumonia (131). 
Pathology of Mycoplasmal Pneumonia of Swine 
îfycoplasmas causing respiratory infections can produce lesions of 
fibrinous pleuropneumonia as exemplified by bovine and caprine contagious 
pleuropneumonia, or a cuffing pneumonia as seen in swine and other animal 
species (35). The main characteristic of this latter type of pneumonia is 
the peribronchial, peribronchiolar, and perivascular accumulation of 
lymphocytes. Although the interstitial lesions found in MPS and similar 
mycoplasmal pneumonias are often described as characteristic of the disease, 
they are nonetheless due to a nonspecific inflammatory reaction in the lungs 
of affected animals. 
Gross lesions of MPS were detected for the first time from 7 (132) 
to 14 days (133) following experimental infection of pigs with M. hyo-
pneumoniae. Small lesions of pneumonia were seen by 3 days post-infection 
in pigs inoculated with a lung suspension which contained both M. hyo-
pneumoniae and M. hyorhinis (134). The lesions consisted of dark red to 
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pale gray areas of consolidation, and catarrhal exudate present mainly in 
bronchi was noted (132,134). During the period from 2 to 6 weeks post­
infection, the gross lesions became more extensive, occasionally affecting 
complete lobes, and were more clearly demarcated from the adjacent normal 
tissue; the affected areas generally became firmer and less exudative (132). 
In the late stage of the disease, from 69 to 262 days post-infection, small 
areas of consolidation caused the lungs to have a fissured appearance (132). 
Pneumonic lesions were found to occur most frequently in the apical and 
cardiac lobes (133,134,135), as well as in the intermediate and cranio-
ventral portions of the diaphragmatic lobes (134,135). Differences in 
distribution of lesions throughout the lungs have been attributed to 
anatomical factors and facility of mycoplasma removal by the mucociliary 
clearance mechanisms of the bronchial epithelium (132,133). 
Enlargement of bronchial and mediastinal lymph nodes were noted by 
the second week post-infection (134) and would probably result from cell 
proliferation observed both in germinal centers (85,119) and in the 
paracortical area (107,119). 
Microscopic examination of lung lesions revealed that lymphocytes 
started accumulating between 5 to 7 days post-infection, and were seen 
first in perivascular (132,134) or peribronchiolar tissues (133). Increase 
of lymphocyte proliferation occurred in the perivascular and particularly 
in the peribronchiolar tissues, and was the most severe between 2 and 6 
weeks post-infection (132,133,126). Proliferation of lymphoid tissue close 
to the airways often resulted in formation of nodules that occasionally 
invaded the lamina propria of bronchioles (132,136). In late stages of the 
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disease, collapsed alveoli, areas of alveolar emphysema, and hyperplastic 
lymphoid nodules associated with bronchioles were observed (132). Oblit­
eration of airways has been found to occur due to the extensive lymphoid 
proliferation around bronchioles (137)• The exact mechanism by which M. 
hyopneumonlae induces lymphocytes to accumulate and proliferate around 
airways and blood vessels is still unresolved. As mentioned previously 
in this review, total numbers of B-lymphocytes in lungs increased fol­
lowing infection (103) and cells of IgA. and IgG isotypes were found to 
have proliferated the most (85). The possibility that T-lymphocytes are 
also involved in development of MPS lesions was raised when it was found 
that pigs with suppressed T-cell response had reduced peribronchiolar 
and perivascular lymphoid hyperplasia (107). Both T- and B-lymphocytes 
have also been found to be increased following M. pulmonis infection in 
rats (99,106). Cell proliferation in the T- (107,119) and B-dependent 
(85,119) areas of regional lymph nodes from infected pigs lends additional 
support for the involvement of both T- and B-cell response in development 
of lesions. 
Initially, the exudate found in the bronchi and in some alveoli con­
sisted mainly of PMNs and macrophages (132,134). As the disease progressed 
more plasma cells were present in the exudate (132,136) and fewer PMNs 
were seen (132). A small number of lymphocytes has also been observed in 
the exudate (136), as well as sloughed alveolar cells (132). In the re­
covering stages, the exudate eventually disappeared (132). 
Colonization of the bronchial epithelium by M. hyopneumoniae (132, 
133,135) or M. hyopneumonlae/M. hyorhinis (134,136) generally resulted in 
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partial or complete loss of cilia. Loss of cilia has also been observed 
in tracheal ring expiants infected with M. hyopneximoniae (138). In late 
stages of the disease (10 weeks or more post-infection), ciliated 
epithelial cells returned to normal (132). 
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SECTION I. ROLE OF MYCOPLASMA HYOPNEUMONIAE MEMBRANES IN THE 
PATHOGENESIS OF MYCOPLASMAL PNEUMONIA OF SWINE 
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SUMMÂRY 
The possible Interactions of cell membranes from Mycoplasma hyopneu-
moniae wtih the porcine immune system and their involvement in the patho­
genesis of mycoplasmal pneumonia of swine (MPS) were investigated. Non­
specific mitogenicity for swine lymphocytes, lesion inducing potential, 
and immunizing properties of M. hyopneumoniae membranes were studied. 
On a few occasions a positive response in the lymphocyte stimula­
tion test was obtained when peripheral blood lymphocytes (PBL) of control 
or uninoculated pigs were used. Following intratracheal (IT) inocula­
tions of M. hyopneumoniae membranes, no detectable effect was noted in 
the response of PBL from membrane-inoculated pigs to stimulation by M. 
hyopneumoniae antigens. Sensitized bronchial lymph node lymphocytes 
(BLNL) could be detected 7 and 14 days post-inoculation. Heating of the 
antigens at 56*C for 60 minutes reduced the response of the BLNL by about 
50%. Pigs given M. hyopneumoniae membranes IT developed mild lesions 
resembling those seen in MPS. Exposure of pigs to membranes before chal­
lenge with live M. hyopneumoniae resulted in a decrease in the severity 
of microscopic lesions of MPS. 
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INTRODUCTION 
Since the first report by Ginsburg and Nicolet (1) that mycoplasmas 
could induce nonspecific proliferation of lymphocytes, several mycoplasma 
species have been shown to stimulate lymphocytes derived from various 
anatomical sites or animal species (2,3,4). The mitogenic activity is 
generally associated with the cell membranes of the organisms (2,3,5) 
although cell-free culture supemate of Mycoplasma arthritidis also contains 
a mitogen (6). Only limited information is available about the biochemical 
composition of these mitogenic factors and variability in specificity and 
biochemical nature has been reported among mitogens from different mycoplasma 
species (7,8). The possibility that M. hyopneumoniae might be mitogenic 
for swine lymphocytes has been mentioned (9,10). In vitro mitogenicity of 
membranes from M. pulmonis has been shown to correlate with ability of 
similar membrane preparations to induce pneumonia when instilled intra-
nasally in rats; lesions of pneumonia were similar to those developing in 
rats infected spontaneously with the organism (11,12). 
Pigs exposed to M. hyopneumoniae develop both cell-mediated and humoral 
immune responses. Procedures used for detection of cell-mediated immunity 
(CMI) to M. hyopneumoniae have included the lymphocyte stimulation test (9,10, 
13,14,15), the leukocyte migration inhibition assay (9,13,15), and intra­
dermal reactivity test (9,13). Humoral responses to the organisms are 
detectable by means of the complement-fixation test (CF) (16), indirect 
hemagglutination test (IHÂ) (17), and enzyme-linked immunosorbent assay 
(ELISÂ) (18). The role of humoral and CMI responses to M. hyopneumoniae in 
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protection or pathogenesis of MPS has not been fully resolved. 
The following experiments were undertaken in order to investigate 
the possible role(s) of membranes from M. hyopneumoniae cells, in the 
pathogenesis of MPS. The iji vitro ability of membranes to nonspecifically 
stimulate lymphocytes as well as their potential to induce lesions of MPS 
in pigs were evaluated. Possible interactions between M. hyopneumoniae 
membranes and swine lymphocytes were further investigated by inoculating 
pigs intratracheally with membranes 1 or 2 weeks before challenge with 
live M. hyopneumoniae. 
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MATERIALS AND METHODS 
Experimental Animals 
Yorkshire pigs, 7 to 10 weeks old, were obtained from a barrier-
maintained, closed herd at the animal resource station at Iowa State Uni­
versity. The herd was originally established from Cesarean-derived, iso­
lation-reared animals. The pigs were fed a 16% protein swine grower ration 
without any growth promoters or other antibacterial substances. Each ex­
perimental group was housed in separate isolation rooms. 
Preparation of Cell Membranes 
The 1262 strain (field isolate, passage 40-42) of M. hyopneumoniae 
was used for preparation of cell membranes. The organisms were grown in 
Friis mycoplasma broth (19,20) with acid adjusted swine serum instead of 
whole serum (21). Mycoplasmas were grown in flasks by shaking (50 rpm) at 
37®C for 3 days in a waterbath.^ Following incubation, the number of color 
changing units (CCU) was determined in order to estimate the number of 
viable organisms. 
Membranes of mycoplasmas were obtained by slight modification of the 
osmotic lysis technique described by Razin (22). Briefly, cells were 
pelleted by centrifugation at 12,000 X g for 15 minutes and washed once 
with a large volume of 0.02M Tris-HCl buffer, pH 7.0. The cells were then 
resuspended in prewarmed (37*C) 2M glycerol (in 0.25M NaCl) solution and 
^Aquatherm Waterbath Shaker, New Brunswick Sci. Comp. Inc., Edison, 
N.J. 
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incubated at 37*C for 15 minutes. The cell suspension was then transferred 
into 50 volumes of warm (37°C) deionized water and incubated at 37®C 
for 15 minutes. The membranes were collected by centrifuging at 26,000 X g 
for 40 minutes and washed once with 0.05M NaCl-G.OlM phosphate buffer, 
pH 7.0. The cells were resuspended in diluted buffer [1/20 dilution of 
0.15M NaCl-0.05M tris (hydroxymethyl) aminomethane-O.OlM 2-mercaptoethanol, 
pH 7.4] and the protein concentration determined according to Lowry et al. 
(23) with bovine plasma proteins^ as the standard. 
For use in the lymphocyte stimulation test, M. hyopneumoniae men±>ranes 
were diluted to 200 yg of protein/ml and stored at -70°C in 1-ml aliquots. 
For intratracheal inoculation of pigs, the membranes were resuspended in 
diluted buffer to give a suspension equivalent to 0.5 to 1.0 x 10^^ ccu/ml. 
Nonviability and sterility of membrane preparations were checked 
by inoculating samples on both Friis mycoplasma agar and broth. Furthermore, 
to ensure complete nonviability of thé membranes administered to pigs 
formaldehyde was added to give a final concentration of 0.25%. 
Experimental Design 
Experiments ^  and 2^ 
Both experiments had the same experimental design, the only difference 
being the number of pigs in each experiment; 10 in experiment 1 and 20 in 
experiment 2. In each experiment the pigs were divided into two groups 
\ab-Trol Chemistry Control, Dade Diagnostics Inc., Aguada, Puerto 
Rico. 
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of equal size. The feed given to animals in these two experiments was 
soaked in water for 5 minutes to obtain a mash and then fed to the pigs. 
This was done to prevent pigs from inhaling feed particles. Pigs in 
one group were inoculated intratracheally (IT) (24) three days in a row 
with 5 ml of M. hyopneumoniae cell membrane suspension. The second 
group of pigs was inoculated in the same manner with the buffer in which 
the membranes were resuspended. In experiment 1, 2 pigs from each group 
were euthanized at 7 days post-inoculation (DPI) and the remaining pigs 
at 14 DPI. In experiment 2, 5 pigs from each group were euthanized at 
7 an 14 DPI, respectively. 
Experiment 2 
This experiment was done to investigate the effects of exposure to 
M. hyopneumoniae cell membranes before challenge with viable M. hyopneu­
moniae. Challenge consisted of 5 ml of a 10% pneumonic lung suspension 
obtained from a pig infected with the field strain M. hyopneumoniae 194 
(isolated at the Veterinary Medical Research Institute, Iowa State 
University). Twelve pigs were divided into 4 groups of equal size. One 
group of pigs (M2) was inoculated three days in a row with M. hyopneu­
moniae membranes and challenged two weeks later. A second group of pigs 
(Ml) was inoculated the same way but one week before challenge. The 
third group (PC) was challenged only with the pneumonic lung suspension. 
Finally, the fourth group (NC) received placebo inoculations. All 
inoculations were done IT. All pigs were euthanized and necropsies done 
on all pigs 14 days post-challenge (DPC). 
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Isolation of Lymphocytes 
Blood samples were obtained by cranial vena cava puncture from the 
pigs before any inoculation was made and at various DPI and/or DFC. 
Heparinized blood samples (20 U heparin/ml of blood) were diluted 1:2 
with phosphate buffered saline solution containing 1% glucose (PBSS-
glucose). The diluted blood was layered on a Ficoll-sodium diatrizoate 
solution (Histopaque-1077^) and centrifuged at 400 X g for 30 minutes at 
room temperature. The peripheral blood lymphocyte (PBL) rich band was 
collected and washed once with PBSS-glucose by centrifuging at 150 X g 
for 10 minutes. Contaminating erythrocytes were lysed by incubating the 
PBL in 0.83% NH^CI-O.OIM phosphate buffer (pH 7.2) for 5 minutes at room 
temperature. The PBL were then washed twice with PBSS-glucose. Following 
the final wash, the PBL were resuspended in RPMI-1640^ medium supplemented 
with fetal bovine serum^ (15%), penicillin^ (50 lU/ml), streptomycin*^ 
(50 yg/ml), kanamycin*^ (50 yg/ml), L-glutamine (2mM) and HEPES (lOmM). The 
PBL were counted and the concentration adjusted to 2 X 10^ lymphocytes/ml. 
Viability as determined by trypan blue dye exclusion test was >98%. 
On days of necropsy, bronchial lymph nodes were aseptically collected 
and placed in Hanks ' balanced salt solution without Ca++ or Ng-H-*^ (HBSS). 
The lymph nodes were minced using a pair of forceps and a scalpel. The 
cell suspension was transferred to a tube and the large pieces allowed to 
^Sigma Chemical Co., St. Louis, Mo. 
*^Flow Laboratories Inc., McLean, Va. 
34 
sediment. The supemate was removed and centrifuged at 150 X g for 
10 minutes at room temperature. Cells were resuspended in NH^Cl-phosphate 
buffer and incubated as above. Bronchial lymph node lymphocytes (BLNL) 
were washed twice with FBSS-glucose and resuspended in supplemented RPMI-
1640. Cell concentration was adjusted to 2 X 10^ lymphocytes/ml. Viability 
of BLN was >90%. 
Lymphocyte Stimulation Test 
Lymphocytes were dispensed in lOO-pl volumes in wells of microtiter 
d c 
plates with equal volumes of concanavalin A type IV (ConA 4 wg/ml), 
phytohemagglutinin A type V^ (PEA 10 vg/ml), pokeweed mitogen^ (PWM 
5 vg/ml), heated (60 minutes at 56*C) or nonheated M. hyopneumoniae cell 
membranes (4 vg/ml) or control medium (BBSS). All cultures were set up in 
triplicate and incubated for 3 days (ConA, PHA, PWM and HBSS), or 5 days 
(ConA, M. hyopneumoniae and HBSS), at 37®C in an atmosphere of 5% CO^ in 
air and high humidity. Eighteen hours before harvesting the respective 
3 e plates, 1 vCi of [ H]-thymidine (specific activity 6.7 Ci/mmol) was 
added to each well. The cells were collected on glass fiber paper strips^ 
using a cell harvester (Microharvester^). After air-djrying, glass fiber 
disks were placed in 4 ml of scintillation cocktail [42 ml of PPO-POPOP 
e 3 
concentrate (Liquifluor ) plus 1000 ml toluene] and [ H]-thymidine 
^ew England Nuclear, Boston, Mass. 
^Bellco Glass Inc., Vineland, N.J. 
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incorporation counted using a liquid scintillation counter.® Results 
were expressed as a stimulation index calculated as follows: SI=cpm 
in stimulated cultures/ cpm in control cultures. Because great variations 
were seem in cpm of control cultures, a SI of 3 or greater was considered 
positive. 
Necropsy 
Following deep anesthesia with pentobarbital sodium, or electrocu­
tion, pigs were exsanguinated. After a piece of the right cardiac lobe 
was taken for microbiologic examination, lungs were removed and examined 
for gross lesions of MPS. The number of lobes with lesions was recorded 
and the lesions were sketched. 
Histopathology 
In experiments 1 and 2, two pieces of lung tissue from the 7 lobes 
of each pig were collected and fixed in 10% buffered formalin. For each 
pig in experiment 3, samples were taken from 4 lobes with lesions when 
possible. Tissues were processed according to standard procedures and 
5 um sections stained with hematoxylin and eosin. Using light microscopy, 
the tissues were examined for presence of lesions characteristic of MPS 
(25). The extent of peribronchiolar and perivascular lymphocytic hyper­
plasia was scored on a scale of 0 to 3; 0=absent; l=focal or mild; 2=multi-
focal or moderate; 3=diffuse or severe. The degree of infiltration of the 
®LS-230, Beckman Instrument, Inc., Fullerton, Ca. 
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bronchiolar lamina propria by lymphocytes was also scored on a scale of 
0 to 3 based upon the amount of cells. 
In experiment 3, the extent of nodular lymphoid formation, adjacent 
or embodied in the peribronchiolar and perivascular lymphocytic tissues, 
as well as the amount of exudate were both scored on a scale of 0 to 3. 
For the nodular formation the same scoring system as above was used. 
For each section, the amount of exudate present was estimated by examin­
ing the entire section under 40X magnification and scoring the amount of 
exudate as follows; 0=absent; 1=25% or less of the section; 2=25 to 50% 
of the section; 3=more than 50% of the section. 
Â total mean lesion score per group was derived by adding the score 
of each criterion evaluated and dividing the total score by the number of 
lobes examined. 
Bacteriologic and Mycoplasmal Cultural Procedures 
All bacteriologic and mycoplasmal cultural procedures used in these 
experiments were similar to those described by Ross et al. (26). In 
experiments 1 and 2, a piece of right cardiac lobe was ground in Friis 
liquid media (without added antibiotics) using a TenBroeck tissue grinder. 
Serial tenfold dilutions of the lung homogenate in Friis broth with 
-4 
methicillin and bacitracin were carried out to 10 . In experiment 3, 
similar procedures were followed except that the lung homogenates were 
diluted through 10 
Samples of secretions from the nasal cavity, trachea, and bronchus 
(left cardiac for experiments 1 and 3; right cardiac for experiment 2) 
were collected with sterile cotton tipped applicators. 
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Serology 
Blood samples were obtained from all pigs at the start of each 
experiment, and at weekly intervals after IT inoculation of membranes 
and/or challenge. Sera were assayed for presence of antibodies to M. 
hyopneumoniae by a modified (16) direct microtiter complement fixation 
test (CF) (27). 
Immunofluorescence 
In experiment 3, lung samples collected from 4 lobes were evaluated 
for presence of M. hyopneumoniae or its antigens using a direct immuno­
fluorescence procedure (28). Samples were collected contiguous to samples 
collected for histopathology and embedded immediately in a glycol-based 
medium (OCT^)• 
Statistical Analysis 
Analysis of variance was used to compare the mean stimulation indices 
of the various groups in each experiment as well as to compare the mean 
microscopic lesion scores in experiments 1 and 2. In experiment 3 the 
mean lesion scores were compared using the t-test. 




Lymphocyte Stimulation Test 
Positive SI with M. hyopneumoniae membranes were obtained in 
lymphocyte stimulation tests before as well as after exposure of the pigs 
to membranes. In experiment 1, the response of PEL from pigs in both 
groups was low and varied from day to day (Figure 1) . Exposure of pigs 
to M. hyopneumoniae membranes did not appear to influence the response of 
PEL to M. hyopneumoniae antigens. 
Marked differences between the groups BLNL responsiveness to membranes 
were noted. The BLNL of membrane-inoculated pigs killed 7 DPI had a mean 
SI of 75.6 compared to 1.7 for control pigs. At 14 DPI, differences 
between the 2 groups were still present but to a lesser degree, 36.1 
compared to 2.7. Heat-treatment of M. hyopneumoniae membranes decreased 
the response of BLNL of membrane-inoculated pigs by about 50% both at 7 
and 14 DPI (Table 1). Although substantial, this reduction was not 
statistically significant (p>.05). 
Slight increases in SI of PEL to M. hyopneumoniae membranes were 
noticed at DPI 6 and 13 in both groups following heat-treatment of membrane 
preparations (Table 1). 
Results in experiment 2 were similar to those in experiment 1 except 
for the response of BLNL from membrane-inoculated pigs (Table 2). Only 
low SI were obtained both at 7 and 14 DPI with BLNL from this group of pigs. 
In experiment 3, exposure to M. hyopneumoniae membranes before 
challenge did not influence the response of PEL at 13 DPC (Table 3). 
Figure 1. Response of PBL from control and membrane-inoculated pigs to 
stimulation by heated (top panel) and nonheated (bottom panel) 
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Table 1. Effect of Intratracheal inoculation of M. hyopneumoniae membranes on lymphocyte 












2 6 PEL 1.6±1.5^ 2.6±1.1 
Control 2 7 BLNL 1.7+0.7 1.8+1.5 
3 13 PBL 3.4+1.7 4.8±1.7 
3 14 BLNL 2.7+1.1 4.1+4.5 
2 6 PBL 1.4±1.0 2.311.5 
Membrane 2 7 BLNL 75.6±40.5 36.2+21.6 
inoculated 3 13 PBL 2.2±0.4 2.8+1.9 
3 14 BLNL 36.1+34.3 15.7±19.1 
*PBL: peripheral blood lymphocytes; BLNL; bronchial lymph node lymphocytes. 
60 minutes. 
^Stimulation index: X±SD. No significant differences were observed (p>.05). 
Table 2. Effect of intratracheal inoculation of M. hyopneumoniae membranes on lymphocyte 












5 6 PBL 2.2±1.0 3.2±1.2 
5 7 BLNL 1.1±0.4 1.5+1.1 
Control 5 13 PBL 3.0±2.0 3.7+3.4 
5 14 BLNL 3.0±4.9 4.0+4.2 
5 6 PBL 2.9±2.0 3.6±2.2 
Membrane 5 7 BLNL 5.5+4.9 3.8+2.9 
inoculated 5 13 PBL 3.5±5.4 4.0±4.2 
5 14 BLNL 8.1±9.8 4.2±3.8 
*PBL: peripheral blood lymphocytes; BLNL; bronchial lymph node lymphocytes. 
^^6*0, 60 minutes. 
^Stimulation index: X±SD. No significant differences were observed (p>.05). 
Table 3. Effect of Intratracheal Inoculation of M. hyopneumonlae membranes on the 
responsiveness of lymphocytes from challenged pigs 
M. hyopneumonlae membranes 
Monheated Heated^ 
b c 
Group Source of cells Source of cells 
(n=No. of 
pigs) PBL BLNL PBL BLNL 
NC(n=3) 2.6+1.6 0.910.5 2.6+1.6 1.3+1.2 
PC(n=3) 2.7+0.7 29.1+35.0 2.7+0.2 10.6+10.9 
Ml(n=3) 2.1+0.7 63.0+56.1 2.5+0.9 18.9±14.4 
M2(n=3) 4.2±2.9 14.5+12.8 3.6±1.6 3.9±3.9 
^56°C, 60 minutes. 
^NC: negative control; PC; positive control; Ml : inoculated with M. hyopneumonlae membranes 
1 week before challenge; M2; inoculated with M. hyopneumoniae membranes 2 weeks before challenge. 
''PBL: peripheral blood lymphocytes, 13 days post-challonge; BLNL: bronchial lymph node 
lymphocytes, 14 days post-challenge. 
'^Stimulation index: X ±SD. 
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Large differences were detected in the SI of BLNL from the three groups 
of pigs infected with M. hyopneumoniae• Seating of the membranes reduced 
the SI of the BLNL by about 65%. 
In all 3 experiments, the SI obtained when lymphocytes were stimulated 
with ConA, PHA, and PWM were almost always >40 and very often >100. 
Bacteriological and Mycoplasmal Isolation 
Very few bacteria were isolated from the lung homogenates. In experi­
ment 1, 5 to 10 colonies of Streptococcus equisimilis were isolated from 
2 pigs, 20 colonies of an alpha-hemolytic streptococcus from 1 pig and 
about 40 colonies of Pseudomonas sp. from 1 pigs. In experiment 2, 
3 colonies of an unidentified gram-positive diphteroid were isolated from 
1 pig, and 10 colonies of Staphylococcus sp. from one other pig. All lung 
homogenates from pigs in experiment 3 were negative for bacteria. 
No M. hyopneumoniae was isolated from the lung homogenates of pigs 
from experiments 1 and 2. Mycoplasma flocculare was isolated from 4 pigs 
in experiment 1 and from 2 pigs in experiment 2. In experiment 3, M. hyo­
pneumoniae was reisolated from all pigs in the PC and M2 groups and from 
2 pigs in the Ml group. 
CF Antibody Testing 
Complement-fixing antibodies were not detected in any pre- or post-
inoculation sera from pigs in experiment 1. In experiment 2, complement-
fixing antibodies were detected in one pig at 6 DPI and in one different 
pig at 13 DPI. In experiment 3, antibodies were detected in sera from 
Table 4. Effect of prior intratracheal inoculation of M. hyopneumoniae 
membranes on development of lesions following challenge with 









No. of pigs 
positive 
No. of lobes 
positives/No. 
examined 
NC(n=3) None None 2 6/21 
PC(n=3) None \ 3 21/21 
Ml(n=3) M. hyopneumoniae 1 
membranes IT 1 
7 days before / 
challenge | 





M2(n=3) M. hyopneumoniae 1 
membranes IT / 
14 days before 
challenge 
3 17/21 
^C: negative control; PC; positive control; Ml; inoculated with 
M.hyopneumoniae membranes 1 week before challenge; M2: inoculated with 
M.hyopneumoniae membranes 2 weeks before challenge. 
Groups with different superscript differ (p<.05). 
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Micro­
scopic Isolation of M. Immuno- Complement 
lesions hyopneumoniae fluorescence fixing antibody 
Mean No. of lobes No. of pigs Mean titer 
lesion No. of pigs No. of pigs positive/No. positive of positive 
score* positive positive examined (day 13) CF test 
1.9+1.6* 0 0 0/12 0 0 
11.0+0.7^ 3 3 10/12 3 65 
7.211.0^ 2 3 8/12 0 0 
9.6+1.0^ 3 3 8/12 3 54 
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3 pigs from both the PC and M2 groups but from none of the pigs from the 
Ml and NC groups. 
Necropsy 
No gross lesion typical of MPS were detected in pigs used in experi­
ments 1 and 2, at 7 or 14 DPI. In experiment 3, gross lesions typical of 
MPS were seen in all pigs that had been challenged with M. hyopneumoniae 
(Table 4). 
Histopathology 
In experiments 1 and 2, microscopic lesions resembling those of MPS 
were detected in pigs inoculated with M. hyopneumoniae membranes (Figure 2). 
The peribronchiolar and perivascular cuffing occasionally accompanied by 
lymphocytic infiltration of the lamina propria were generally limited to a 
few areas in the sections. Inflammatory cells were not observed in alveoli 
of any section. Mild accumulation of lymphocytes around bronchioles was 
observed in some of the sections from control pigs. This was assumed to be 
normal bronchial-associated lymphoid tissue. 
In experiment 1, membrane-inoculated pigs killed 7 DPI had signifi­
cantly more (p<.01) microscopic lesions than control pigs killed on the same 
day (Table 5). Peribronchiolar and perivascular lymphocytic cuffing was 
generally more pronounced in the former group, as was also infiltration of 
the lamina propria of airways by lymphocytes. 
In experiment 2, membrane-inoculated pigs killed on DPI 14 had a 
significantly higher (p<.05) mean microscopic lesion score than control pigs 
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killed on the saune day (Table 5). Increased lymphocytic proliferation 
around bronchioles and blood vessels accounted for the major difference 
between the two groups. 
Microscopic evaluation of lung sections from pigs used in experiment 
3 revealed significant differences in mean microscopic lesion scores ob­
tained with the 4 groups (Table 4). Pigs inoculated with membranes 2 
weeks (M2) or 1 week (Ml) before challenge had significantly less (p<.05) 
microscopic lesions of MPS than the positive control group (PC). Reduc­
tion in severity of lesions was mainly due to decreased amount of inflam­
matory cells in alveoli and bronchioles, and slight reduction of peribron­
chiolar and perivascular lymphocytic proliferation. 
Immuno fluorescence 
Fluorescent-antibody technique was done only on lung samples from 
pigs of experiment 3. All animals that had been challenged with M. hyo-
pneumoniae were FA positive (Table 4). Both the Ml and M2 groups had 
a slightly lower number of positive lobes than the PC group (Table 4). 
No difference in the intensity of positive response was noted between 
the 3 groups. 
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Figure 2. Peribronchiolar lymphoid hyperplasia in 
lungs from membrane-inoculated pig, 
7 DPI. 51X 
Table 5. Individual and mean microscopic lesion score of pneumonia of pigs Inoculated 
intratracheally with M. hyopneumonlae membranes 
Microscopic lesion score 
Days post-
Experiment inoculation Group Individual pigs Mean 
Control 0.57 2.57 1.57*1.22**'® 
7 Membrane-
Inoculated 4.00 3.42 3.7U1.22** 
1 
14 
Control 2.86 2.00 4.00 2.95-1.47 
Membrane-
Inoculated 3.86 2.00 1.43 2.43*1.36 
7 
Control 0.57 0.29 1.71 1.43 1.57 1.11*1.32 
Membrane-
Inoculated 0.71 0.80 1.29 1.57 1.14 1.11*1.20 
2 
14 
Control 0.71 0.71 1.57 2.14 2.29 1.48*1.22* 
Membrane-




Nonspecific mitogenic activity for lymphocytes from various animal 
species or anatomical sites has been demonstrated with several Mycoplasma 
species (1,2,3,4). Results presented here indicated that M. hyopneumoniae 
membranes stimulated porcine PEL only slightly and somewhat inconsistently 
(Figure 1). A possible nonspecific mitogenic activity associated with 
M. hyopneumoniae has been reported previously (9,10). The authors found 
that invactivated whole organisms produced a positive SI with PEL from 
noninfected pigs. However, Kishima et al. (14) were unable to detect a 
nonspecific stimulatory effect when using sodium azide killed whole M. 
hyopneumoniae. In the present study , heat-treatment of the membranes used 
as antigens in the lymphocyte stimulation test generally resulted in a 
slight increase in nonspecific stimulation of PEL. Heat-stable mitogenic 
factors have been reported in M. arthritidis, M. hyosynoviae, M. hominis, 
and M. arginini (4). 
Response of BLNL to M. hyopneumoniae membranes in all three experi­
ments tended to indicate that a population of sensitized lymphocytes 
develops in the regional lymph nodes following intratracheal inoculation 
of killed or live organisms. Substances responsible for stimulation of 
the lymphocytes in sensitized pigs appeared to be proteinaceous or to 
contain protein material since heating of the membranes reduced the SI 
by approximately 50% (Tables 1, 2, and 3). It should be .noted however, 
that heat-treatment of membranes did not completely abolish their ability 
to stimulate the BLNL. The SI of BLNL from pigs given membranes or 
52 
infected with M. hyopneumoniae were generally higher than those obtained 
with BLNL from control pigs. This response was probably primarily in 
response to the heat-resistant antigen(s) on the membranes. 
Kristensen et al. (10) found no evidence that lymphocytes from 
bronchial lymph nodes of M. hyopneumoniae infected animals were sensitized 
to the organism, although PBL from the same pigs were responsive to 
stimulation by the antigen. Length of time since exposure to M. hyo­
pneumoniae antigens might account for the differences observed in re­
sponsiveness of regional lymphocytes in the above study and the present 
work. In the present study, BLNL were stimulated either 1 or 2 weeks after 
IT inoculation of membranes, or 2 weeks after challenge with live M. hyo­
pneumoniae. Kristensen et al. (10) on the other hand, assayed BLNL 5 weeks 
after pigs had been contact-exposed to M. hyopneumoniae infected pigs. 
It is possible that the number of sensitized lymphocytes present in the 
lymph nodes of their swine was too low to be detected. 
Kishima et al. (14) reported that heating of M. hyopneumoniae antigen 
preparation at 60®C for 30 minutes greatly enhanced stimulation of PBL. 
As noted above, in the present study heat-treatment of M. hyopneumoniae 
antigen resulted in a decrease of the SI of BLNL. The initial route of 
inoculation of antigen, and use of dextran sulfate in the former study 
might have induced sensitization to different antigens and could explain 
the differences noted in heat stability of these antigens. 
Contrary to the BLNL, no highly sensitized PBL could be detected 
following IT inoculation of M. hyopneumoniae membranes and/or live 
M. hyopneumoniae. These results were not surprising for experiments 1 
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and 2, since the animals were euthanized early following the inoculations 
and sensitized lymphocytes might not have entered the pool of circulating 
lymphocytes. Results obtained in experiment 3 gave no clear evidence 
that PBL were sensitized but it was noted that pigs in contact with 
M. hyopneumoniae antigens the longest (group M2) had the highest SI. 
These SI were in the range of values obtained with PBL from M. hyopneumo­
niae infected pigs in other studies. 
The origin of M. flocculare isolated from pigs in experiment 1 and 
2 is unknown. M. flocculare is generally considered nonpathogenic for 
swine (29). In our experiments, it was isolated from pigs in both groups 
and although no significant difference in the various responses of pigs 
within a group could be noted, the possibility that Interference with one 
or more of the tests performed still exists. 
M. hyopneumoniae was reisolated from 2 out 3 pigs in the Ml group. 
Also, all pigs in that group were seronegative (Table 4), and the BLNL of 
this group had the highest SI (Table 3). This might suggest that a local 
population of lymphocytes temporarily impeded growth of M. hyopneumoniae 
in the lung without complete clearing the infection. This was evidenced 
by detection of mycoplasmal antigens in lung sections by FA. This effect 
appears transient since no difference in seroconversion could be seen 
between the PC and M2 groups. The possibility of temporary Interference 
with growth of the organisms in the lungs was further supported by the 
results of the microscopic evaluation of the lungs (Table 4), where pigs 
inoculated with membranes before challenge had a significant reduction in 
severity of lesions. Induction of local humoral immune factors following 
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IT inoculation of M. hyopneumonlae membranes might have prevented or 
impeded development of lesions normally seen in MPS. Tajima et al. (30) 
reported that suppression of cell-mediated immune mechanisms of pigs by 
thymectomy and treatment with antithymocyte antisera reduced the severity 
of microscopic lesions of MPS. Following suppression of cell-mediated 
immunity, similar observations were made in mice infected with M. pulmonis 
(31) and hamsters infected with M. pneumoniae (32,33). 
Naot et al. (11,12) correlated the mitogenic activity of M. pulmonis 
membranes with pathogenicity of the organism ^  vivo after they demonstrated 
that intranasal administration of membranes to rats induced lesions similar 
to those occurring in natural infection. Naot et al. (12) indicated that 
the severity of microscopic lesions of pneumonia induced in Hooded and 
Lewis rats by administration of H. pulmonis membranes was directly related 
to the degree of vitro responsiveness of lymphocytes from these rat 
strains to similar membrane preparations of this organism. 
Our preparations of M. hyopneumoniae membranes had weak mitogenic 
activity for pig lymphocytes and might explain why only mild microscopic 
lesions resembling those of HPS could be induced in pigs having received 
membranes IT. 
Another possible explanation for the presence of only mild lesions 
is that an insufficient amount of membranes was administered in relation 
to the volume of the porcine lung. Also, the size of the area evaluated 
by microscopic examination is so minimal in regards to the whole lung 
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SECTION II. STIMULATION OF LYMPHOCYTES FROM, AND INOCULATION OF 
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SUMMARY 
Nonspecific mitogenicity of Mycoplasma hyopneumoniae membranes for 
swine lymphocytes and potential for these membranes to induce lesions seen 
in mycoplasmal pneumonia of swine (MPS) were investigated. Membranes were 
prepared by osmotic lysis of mycoplasmal cells and administered intratra-
cheally (IT) to 5-week-old, Cesarean-derived, colostrum-deprived pigs. 
Seven days post—inoculation pigs were necropsied and lungs examined for 
presence of gross and microscopic lesions. Nonspecific and specific lym­
phocyte stimulation responses were determined using peripheral blood lym­
phocytes (PBL) collected before and after IT inoculation and bronchial 
lymph node lymphocytes (BLNL) collected at necropsy. 
Examination of lungs from membrane-inoculated pigs revealed no gross 
lesions; however, microscopic lesions consisting of mild perivascular and 
peribronchiolar lymphoid hyperplasia with occasional penetration of the 
muscular layer by lymphocytes were seen in the submucosa of bronchioles. 
The distribution of microscopic lesions in the different regions of the 
lungs did not have any specific pattern and were seen in every lobe at one 
time or another in these experiments. Although substantially less severe 
the lesions resembled those found in lungs of pigs infected with virulent 
M. hyopneumoniae. 
Positive stimulation of PBL from control and membrane-inoculated pigs 
by M. hyopneumoniae membranes was detected on all but one occasion. Mean 
stimulation indices (SI) ranged from 2.8 to 17.4 for control pigs and from 
3.7 to 9.9 for membrane-inoculated pigs. The response appeared to be 
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nonspecific in nature. BLNL from control and membrane-inoculated pigs 
were also stimulated by membrane preparations. Contrary to PEL, the 
response of BLNL appeared to be influenced by previous exposure to the 
membranes, control pigs having SI ranging from 3.0 to 16.5 whereas SI 
for membrane-inoculated pig ranged from 18.6 to 25.5. 
The findings indicate that M. hyopneumoniae has some degree of non­
specific mitogenicity for swine lymphocytes and that this mitogenic 
activity might have a role in development of MPS lesions. 
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INTRODUCTION 
The nonsepcific mitogenicity of various mycoplasmas for lymphocytes 
from different animal species has been recognized for several years (1,2, 
3,4). This mitogenic activity has been associated with ^ ole cell (3,4, 
5), membrane (2,3,4,6,7,8,9), and supemate (10,11,12) preparations from 
mycoplasma cultures. In the case of Mycoplasma pulmonis, a link has been 
established between mitogenic activity for rat lymphocytes and the devel­
opment of lesions of pneumonia following intranasal inoculation of rats 
with membranes prepared from that organism (13,14). 
Mitogenicity of M. hyopneumoniae for swine lymphocytes has been 
reported as a sporadic event (15,16); however we recently obtained more 
convincing evidence that the organism is mitogenic for swine lymphocytes 
(17). Furthermore, microscopic lesions of pneumonia resembling those 
seen in MPS developed in the same swine following IT inoculation with M. 
hyopneumoniae membranes. Unfortunately, the basis for development of 
the lesions was not clearly determined because Mycoplasma flocculare, an 
organism closely related to M. hyopneumoniae, was isolated from a few of 
the swine. 
In the present report, we provide further evidence of the pathogenic 
potential of M. hyopne"i""niae membranes by demonstrating that they are 
mitogenic for unsensitized lymphocytes from Cesarean-derived, colostrum-
deprived swine and that they induce lesions in such swine when given IT. 
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MATERIALS AND METHODS 
Experimental Animals 
Cesarean-derived, colostrum-deprived (CDCD), 5-week-old Yorkshire 
pigs were purchased from a commercial supplier (Merrick-Struve Labora­
tories, Manilla, lA). Animals were housed in groups of three, in plexi­
glass isolation chambers ventilated with air filtered through fiberglass 
filter medium.^ They were fed a nonpelleted, 18% protein swine starter 
ration without any growth promoters or other antibacterial substances. 
Experimental Design 
The same experimental design was followed in each of the two ex­
periments comprising this study except that the number of pigs in each 
experiment varied. In the first experiment, 2 groups of 3 pigs each were 
used whereas 4 groups of 3 pigs each were used in the second experiment. 
In each experiment, half of the pigs were inoculated IT (18) 3 days in 
a row with 5 ml of M. hyopneumoniae membrane suspension and the other half 
inoculated with 5 ml of buffer with formaldehyde but without membranes. 
Blood samples for PBL isolation and serum collection were taken 
once before and at 2 and 6 days post-inoculation (DPI). All pigs were 
killed and necropsied 7 DPI. 
^American Adr Filter Company, Inc., Zion, 111. 
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Mycoplasma hyopneumoniae Membranes 
The 1262 strain of M. hyopneumoniae, isolated originally from a field 
case of MPS, triple-cloned and in the 40-42 passage^, was used to prepare 
membrane suspensions for IT inoculations and antigen for the lymphocyte 
stimulation test. Mycoplasmas were grown in Friis mycoplasma broth (19,20) 
with acid adjusted serum (21) for 3 days at 37*C in a shaking waterbath.*^ 
Membranes were obtained by an osmotic shock technique described previously 
(17). 
For use in the lymphocyte stimulation test, M. hyopneumoniae mem­
branes were diluted to 200 ^ g of protein/ml in a 1/20 dilution of 0.15M 
NaCl-0.05M tris (hydroxymethyl) aminomethane-O.OlM 2-mercaptoethanol 
buffer and stored at -70°C in 1-ml aliquots. Protein concentration was 
determined according to Lowry et al. (22) with bovine plasma proteins^ 
as the standard. For the IT inoculation, the membranes were resuspended 
in the same buffer as above to give a suspension equivalent to 1 X 10^^ 
color changing units per ml of viable whole cells. Nonviability and ste­
rility of the membrane preparations were checked by inoculating samples 
^B. Zimmermann-Erickson, Veterinary Medical Research Institute, 
âmes, la. 
^Aquatherm Waterbath Shaker, New Brunswick Sci. Comp., Inc., Edison, 
N.J. 
^Lab-Trol Chemistry Control, Cade Diagnostics Inc., Agaada, 
Puerto Rico. 
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on both Frils mycoplasma agar and broth. Furthermore, to ensure com­
plete nonvlablllty of membrane preparations administered to pigs 
formaldehyde was added to give a final concentration of 0.25%. 
Isolation of Lymphocytes 
Heparinized blood samples (20 U heparin/ml of blood) were diluted 
1:2 with phosphate buffered saline solution containing 1% glucose and 
PBL isolated by density centrifugation on Ficoll-sodium diatrizoate 
solution (Histopaque-1077®) as described previously (17). On days of 
necropsy, bronchial lymph nodes were aseptically collected and placed 
in Hanks' balanced salt solution without Ca^ or Mg^^ (HESS). 
Bronchial lymph node lymphocyte suspensions were prepared as described 
previously (17). 
Lymphocyte Stimulation Test 
Lymphocytes were dispensed in 100 ul volumes in the wells of micro-
if 0 
titer plates with equal volumes of concanavalin A type IV (Con A, 
4 yg/ml), phytohemagglutinin A type V® (PEA 10 vg/ml), pokeweed mitogen® 
(PWM 5 vg/ml), heated (60 min. at 56*C) or nonheated M. hyopneumoniae 
cell membranes (4 vg/ml) or control medium (BBSS). All cultures were set 
up in triplicate and incubated for 3 days (Con A, PEA, PWM, and BBSS), 
®Sigma Chemical Co., St. Louis, Mo. 
^Flow Laboratories Inc., McLean, Va. 
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or 5 days (Con A, M. hyopneumonlae, and BBSS) at 37®C in an atmosphere 
of 5% COg in air and high humidity. Labeling and counting of incorporated 
[^H]-thymidine® (specific activity 6.7 Ci/mM) was done as described 
previously (17)• 
Necropsy 
Anesthesia was induced by intravenous injection of pentobarbital 
sodium and pigs were exsanguinated. After a piece of the right cardiac 
lobe was taken for microbiologic examination, lungs were removed and 
examined for gross lesions. 
Histopathology 
Five samples of lung tissue were taken from each of the 7 lobes of 
every pig and fixed in 10% formalin. Tissues were cut at 5 um, processed 
according to standard procedures and sections stained with hematoxylin 
and eosin. Using light microscopy, tissues were examined for presence of 
lesions characteristic of MPS (23). For each section, individual scores 
on a scale of 0 to 3 (17) were given to quantify the extent of perivas­
cular and peribronchiolar lymphoid hyperplasia, the extent of lymphocyte 
accumulation in the submucosa of bronchioles, and the amount of exudate 
in the airways and alveoli. A cumulative score was then derived for each 
group of pigs (17). 
^ev England Nuclear, Boston, Mass. 
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Bactériologie and Mycoplasmal Cultural Procedures 
Â piece of right cardiac lobe was ground in Friis liquid media 
(without added antibiotics) using a TenBroeck tissue grinder. Serial 
tenfold dilutions of the lung homogenate were made in Friss broth with 
methicillin and bacitracin. Samples of secretions from the nasal cavity, 
trachea, and left bronchus were collected with sterile cotton-tipped 
applicators. All bacteriologic and mycoplasmal cultural procedures used 
were similar to those described by Ross et al. (24). 
Complement-Fixation Test 
All serum samples collected were assayed for presence of antibodies 
to M. hyopneumoniae using a modified (25) direct cicrotiter complement-
fixation test (CF) (26). 
Statistical Analysis 
Analysis of variance was used to compare the SI of control and 
membrane-inoculated groups in each of the 2 experiments. 
Double-sided Student t-test was used to compare the mean lesion 





Examination at necropsy revealed no evidence of gross lesions of 
pneumonia in lungs of control or membrane-inoculated pigs in either ex­
periment. Upon microscopic examination of lung sections from control 
pigs in both experiments, no lymphocytes were seen around blood vessels 
but variable numbers of lymphocytes were present around bronchioles. Mild 
(Figure 1) to moderate (Figure 2) focal accumulations of lymphocytes were 
seen in lungs of all membrane-inoculated pigs. The lesions did not have 
any specific pattern of distribution throughout the different regions of 
the lungs and were seen in every lobe at one time or another during the 
course of these experiments. Accumulation of lymphocytes was seen around 
both blood vessels and bronchioles but was most frequent around bronchio­
les. Occasionally, lymphocytes infiltrated the submucosa of bronchioles 
and collected between the bronchial epithelium and the muscular layer 
surrounding the bronchioles (Figure 3). The lymphoid hyperplasia in the 
submucosa of airways or in the peribronchiolar and perivascular areas was 
occasionally organized into nodule formations. These nodules had mild to 
moderate development and on rare occasions protruded into the lumena of 
airways (Figure 4). 
In the first experiment, although lesions were seen in lungs of mem­
brane-inoculated pigs the mean lesion score was not significantly differ­
ent from the score of control pigs because of the mildness of the lesions 
observed in the samples (Table 1). However, in the second experiment 
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•Figure 1. Mild peribronchiolar lymphoid hyperplasia in 
lungs from membrane-inoculated pig, 7 DPI. 80X 
J 
m  -  - -  —a 
4 
. - _• - - ^ 
Figure 2. Moderate peribronchiolar lyn:phoid hyperplasia in 
Troût ûîcïûbrâne—iriOCu^àucû pigy 7 DPI# 12SX 
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Figure 3. Moderate peribronchiolar lymphoid hyperplasia 
with penetration of the muscular layer by 
lymphocytes. Membrane-inoculated pig, 7 DPI. lOOX 
Figure 4. Lymphocytes in submucosa of bronchiole organized 
into nodule formation protruding into the lumen. 
Membrane-inoculated pig, 7 DPI. 96X 
Table 1. Individual and mean microscopic lesion score of pneumonia of 
pigs inoculated intratracheally with M. hyopneumonlae membranes 
Microscopic lesion score 
Experiment Group Individual pigs Mean 
1" 
Control 0.00 0.00 0.00 0.00 ± 0.00+ 
Membrane-
Inoculated 
0.29 0.71 1.29 0.76 ± 0.50 
2 
Control 1.00 0.00 0.71 0.29 0.57 0.29 0.47 ± 0.36* 
Membrane-
Inoculated 1.29 0.71 1.43 0.86 1.59 1.43 1.22 
+ 0.35^ 
Groups with different superscript differ (p<.01). 
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membrane-Inoculated pigs had a significantly higher (p<.01) mean lesion 
score than control pigs (Table 1). Differences in individual score were 
seen in each group in both experiments. Microscopic lesions were slightly 
more pronounced in membrane—inoculated pigs of the second experiment 
(Table 1). The development of peribronchiolar lymphoid tissue in control 
pigs was highly variable and was found more abundant in pigs of the second 
experiment (Table 1). The 3 control pigs in experiment 1 received a score 
of 0 due to the very limited development of peribronchiolar lymphoid tis­
sue. 
Lymphocyte Stimulation Test 
Lymphocytes collected from blood of pigs in all groups prior to IT 
inoculation were stimulated by M. hyopneumoniae membranes (Table 2). In 
general, stimulation of pre-inoculation PBL was obtained with heated and 
nonheated membranes except that no significant response was detected with 
PBL from control pigs using nonheated membranes in experiment 2 (Table 2). 
Stimulation indices obtained pre-inoculation and 2 DPI with PBL from 
membrane—inoculated pigs were slightly, but not significantly, higher than 
those from control pigs regardless of whether or not the membrane suspen­
sions were heated. At 6 DPI positive SI were again found following sti­
mulation of PBL by M. hyopneumoniae membranes (Table 2). In the second 
experiment, the PBL from control pigs had higher SI than membrane-inocu­
lated pigs when heated or nonheated M. hyopneumoniae were used. 
When BLNL were exposed to M. hyopneumoniae membranes positive SI 
were obtained with lymphocytes from-all groups (Table 3). In the first 
experiment, higher but not significantly different indices were obtained 
Table 2. Effect of intratracheal inoculation of M. hyopneutnonlae membranes on responsiveness 
















A.2±2.5 3.9±3.8 8.3*2.6 3.7±2.7 6.5±3.1 17.4^12.2 
3.6±0.6 3.0*1.7 5.2±0.2 2.8*1.1 6.4*2.5 10.4*6.1 
4.8*2.4 7.6*6.0 8.2*3.8 7.1*2.4 9.9*6.3 8.3*4.0 
3.7*2.8 5.6*2.3 7.3*3.4 4.3*3.3 8.5*5.3 8.1*2.9 
®56°C, 60 minutes. 
^Stimulation index: X±SD. 
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Table 3. Effect of intratracheal inoculation of M. hyopneumoniae 
membranes on responsiveness of bronchial lymph node 
lymphocytes to the organism 
Experiment 
M.hyopneumoniae membranes 
(n=No. of pigs 
per group) Group Heated® Nonheated 
Control 3.0±1.2+ 3.2±1.5 
(n=3) Membrane-
Inoculated 18.6±10.6 21.4±15.3 
2 
Control 16.5±10.6 11.1±8.9 
(n=6) Membrane-
Inoculated 25.5±15.0 19.8±10.9 
®56°C, 60 minutes. 
^Stimulation index: XfSD. 
75 
with lymphocytes from membrane—inoculated pigs than with lymphocytes from 
control pigs. Comparison of SI obtained with BLNL from control pigs in 
the two experiments revealed much higher responses in the second experi­
ment. Even though the SI of BLNL from control pigs in the second experi­
ment were large, the SI of BLNL from membrane-inoculated pigs were larger 
when both heated and nonheated membranes were used (Table 3). 
The response of PBL to stimulation by ConA, PHA, and PWM was highly 
variable from day to day in both groups and in each experiment but no 
consistent difference between control and inoculated pigs could be detec­
ted (Table 4). Stimulation of BLNL by ConA, PHA, and PWM also gave highly 
variable SI and again no difference between groups seemed to exist (Table 
4). 
Bacteriology 
Bordetella bronchiseptica, Pasteurella multocida, or Haemophilus spp. 
were not isolated from samples from the nasal cavity, trachea, bronchus 
or lung of control or membrane-inoculated pigs in either experiment. 
Similarly, mycoplasma were not isolated from lung homogenates from any 
of the pigs. 
Table 4. Response of lymphocytes to stimulation by various mitogens 
Days post-inoculation 
(origin of cells)^ 
Experiment 
(n=No. of pigs) 





ConA 47.3±44.3 35.1*29.5 
Control PHA 33.1+21.0 71.0±61.9 














ConA 32.1^30.8 50.4*49.9 
Control PHA' 92.1*78.2 157.3*150.5 
o 














^PB; peripheral blood; BLN; bronchial lymph node. 
^ConA; concanavalin A (4/ag/ml); PHA: phytohemagglutinin 
(10 pg/ml); PWM; pokeweed mitogen (5 fig/ml). 
































In the present study, IT inoculation of CDCD pigs with membrane prep­
arations of M. hyopneumoniae induced microscopic lesions of perivascular 
and peribronchiolar lymphocytic hyperplasia resembling those seen in MPS. 
Previous experiments had indicated that similar membrane preparations 
could also induce this type of lesions in conventionally-reared pigs (17). 
The microscopic lesions observed were far less severe than what is 
seen in natural or experimental infection with viable organisms. Micro­
scopic lesions are generally detectable in lungs of pigs 7 days following 
exposure to M. hyopneumoniae (22). Presence of viable replicating M. hyo­
pneumoniae in lungs of infected pigs could cause continued stimulation of 
lymphocytes by mitogen associated with this organism and might explain 
the increased severity of lesions in natural and experimental infection. 
This sustained stimulation of lymphocytes could also account for the long 
duration of MPS. 
The potential for nonspecific mitogen to initiate or exacerbate lung 
disease has to be considered especially in light of the fact that concana-
valin A, a nonspecific mitogen, induced lesions of interstitial pneumonia 
when administered intranasally to rats (13). The highly contaminated air 
present in swine confinement housing (27,28) could be a source of nonspe­
cific mitogen such as endotoxin of gram-negative bacteria (28) and possi­
bly mycoplasma in infected herds. 
Although the experiments were not done at the same time, the response 
of conventionally—reared and CDCD pigs to the membranes appeared to be 
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similar. However, severity of microscopic lesions was less pronounced in 
CDCO pigs than in conventionally-reared pigs. A possible explanation for 
the difference in severity of microscopic lesions could be that cell pop­
ulations or cell numbers in the lungs or regional lymph nodes of the two 
groups of pigs differed. CDCD pigs were less exposed to stimulation by 
the environment and thus their local immune system would be less prepared 
to react to membrane exposure. In studies on lung lavage fluid nonspeci­
fic antigenic stimulation was required in order to elicit a population of 
resident macrophages in airways of CDCD piglets (29). Additionally, a 
significantly lower proportion of T-helper lymphocytes has been observed 
in spleens of germ-free mice compared to conventional mice (30). The 
percentage of antibody producing cells in spleens of each type of mice 
were not different. 
Thymectomy has been shown to reduce the severity of microscopic le­
sions developing following infection with M. pulmonis in mice (31), Myco­
plasma pneumoniae in hamsters (32), and M. hyopneumoniae in pigs (33). 
Although these findings provided evidence for the role of T-lymphocytes 
in lesion development it is highly probable that their presence in the 
lungs is necessary to help control the infection because mycoplasmas were 
able to multiply to much higher numbers in the lungs (31,32,33) and to 
invade other organs in thymectomyzed animals (31). The T-lymphocytes 
could control the infection by interacting directly with mycoplasmas but 
they are more likely to have a helper role since local humoral responses 
are generally thought to be of major importance in controlling respirato­
ry mycoplasmoses (34,35,36). 
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As noted previously (17) the response of PBL to membrane preparations 
did not appear to be influenced by previous exposure of the pigs to mem­
branes. However, positive stimulation of PBL was found in all but one 
instance in the present experiments and was sporadically encountered in 
previous ones (17). Mitogenic factors associated with various mycoplas­
mas have been found to stimulate T (11,12), B (4,5,8,9), or both (2,6,7) 
populations of lymphocytes from various animal species. Possible differ­
ences in ratio of lymphocytes subpopulations between CDCD and conven­
tionally-reared pigs combined with preferential stimulation of one of 
these subpopulations could explain the differences noted in stimulation 
of PBL. 
Positive SI observed with BLNL from control pigs were fairly large 
in the second experiment but still the response of BLNL appeared to be 
influenced by previous exposure to the membranes since BLNL from membrane-
inoculated pigs had higher SI than control pigs in each experiment. This 
probably results from sensitization of lymphocytes in the lungs to M. 
hyopneumoniae followed by local traffic of lymphocytes to the regional 
lymph nodes. Earlier studies (17,36) indicated that a substance contain­
ing protein was a likely candidate responsible for sensitizing lympho­
cytes due to its susceptibility to heat treatment. In the first experi­
ment of this study, heat treatment of the membranes reduced the response 
of BLNL to stimulation. However, in the second experiment, higher SI were 
observed with BLNL following heat treatment of the membranes. This was 
observed with BLNL from both control and membrane-inoculated pigs which 
might indicate that although specific stimulation of BLNL from membrane-
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inoculated pigs could be taking place, nonspecific stimulation by membra­
nes would be prevalent in this case. 
In previous experiments (17) , detection of positive SI concurrently 
with isolation of M. flocculare from the lungs of some pigs raised the 
question as to whether or not this mycoplasma influenced the response of 
BLNL to stimulation by M. hyopneumoniae membranes. This point was brought 
about because of the antigenic relatedness found between these two myco­
plasmas by agar gel diffusion, CF test, immunofluorescence, and growth 
precipitation test (37) as well as by two-dimensional Immunoelectrophore­
sis (38). In the current experiments, obtaining positive SI with lympho­
cytes from CDCD pigs from which no porcine mycoplasmas were isolated con­
firms the mitogenic and lesion inducing potential of membranes from M. 
hyopneumoniae for swine lymphocytes. 
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SECTION III. HUMORAL AND CELL-MEDIATED IMMUNE RESPONSES OF 
PIGS FOLLOWING EXPERIMENTAL MYCOPLASMA 
HYOPNEUMONIAE INFECTION 
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SUMMARY 
The cell-mediated and humoral immune responses of pigs following 
experimental Mycoplasma hyopneumoniae infection were investigated. The 
response of peripheral blood (PBL) and bronchial lymph node (BLNL) 
lymphocytes to stimulation by M. hyopneumoniae antigens was evaluated by 
lymphocyte stimulation test and presence of specific antibodies in serum 
and lung washing (LW) samples assayed by complement-fixation test ( CF) 
and ELISA. Additionally, immunoglobulin-positive cells in lung and 
bronchial lymph node (BLN) were identified by indirect fluorescent antibody 
test (IFA). Positive stimulation of PBL from infected and noninfected 
pigs occurred on every occasion PBL were tested and lymphocytes from 
infected pigs generally had higher stimulation indices (SI). The response 
of BLNL appeared more antigen-specific and BLNL from infected pigs had 
significantly higher SI at 2 and 6 weeks post-inoculation. CF antibodies 
to M. hyopneumoniae were detected in sera and LW from infected pigs. The 
ELISA indicated that IgA antibodies predominated in LW from most infected 
pigs and the intensity of the reaction exhibited by the IgG antibodies 
increased over the course of the infection. Cells producing IgM and IgA 
isotypes were found in lungs of all pigs but IgG-positive cells were 
present only in lungs of infected pigs. Of all the immune responses develop­
ing in mycoplasmal pneumonia of swine, the local humoral response seems to 
better parallel recovery from the disease. 
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INTRODUCTION 
Both cell-mediated and humoral immune responses to Mycoplasma 
hyopneumoniae have been detected following experimental infection (1) 
or vaccination (2,3) but their exact role in protection against, or in 
pathogenesis of mycoplasmal pneumonia of swine (MPS) have not been fully 
resolved. The local humoral response was found to be important in pro­
viding some degree of protection against mycoplasmal pneumonias similar 
to MPS occurring in other animal species (4,5,6,7). The importance of 
this immune response in MPS was suggested when the percentage and total 
number of B-lymphocytes in lungs increased following infection with M. 
hyopneumoniae (8). The number of immunoglobulin-producing cells in lung 
tissue, as well as antibody titers to M. hyopneumoniae in tracheobronchial 
secretions increased during the course of experimental MPS (9). Suppression 
of T-cell response, achieved by thymectomy, injection of antithymocyte 
serum, or treatment with cyclophosphamide, and subsequent infection of 
animals with mycoplasma species known to cause pneumonia resulted in 
development of less severe microscopic lesions of pneumonia than in immuno­
competent infected animals (10,11,12,13). But at the same time, suppres­
sion of this immune response allowed mycoplasmas to grow and reach numbers 
10 to 1000 fold higher than in immunocompetent infected animals (10,12,13, 
14). Also, spread of mycoplasmas to other organs occurred more frequently 
in immunosuppressed infected animals (10). 
In an attempt to help elucidate the role of the innmine response in the 
pathogenesis of MPS, the local and systemic humoral and cell-mediated 
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immune responses of pigs experimentally infected with M. hyopneinaoniae 
were investigated. 
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MTERIALS AND METHODS 
Experimental Animals 
Yorkshire and Hampshire pigs, 7 to 10 weeks old, of both sexes were 
obtained from a barrier-maintained, closed herd at the animal resource 
station at Iowa State University. The herd was originally established 
from Cesarean-derived, isolation-reared animals. The pigs were fed a 
16% protein swine grower ration without any growth promoters or other 
antibacterial substances. Pigs were housed in four groups of seven 
animals in separate isolation rooms. 
Experimental Design 
Twenty-eight pigs were randomly distributed on the basis of litter 
and sex into two groups of equal size. Pigs in one group were each 
inoculated once intratracheally (IT) (15) with 5 ml of 10% pneumonic lung 
suspension containing M. hyopneumoniae. This pig-passaged lung inoculum, 
designated M. hyopneumoniae strain 194, was derived from a field case of 
MPS and has been shown to be free of detectable bacteria, mycoplasmas 
other than M. hyopneumoniae and viruses. The other group received a 
placebo inoculation IT consisting of mycoplasma culture broth. 
Blood samples were collected for peripheral blood lymphocytes (?BL) 
isolation and serum collection once before and at weekly intervals 
following inoculation. Pigs were killed and necropsies done on five pigs 
from each group at 2 and 4 weeks post-inoculation (WPI) and on the 
remaining pigs at 6 WPI. 
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Mycoplasma hyopnetimoniae Membranes 
The 194 strain (field isolate, passage 7) of M. hyopneumoniae was 
used to prepare the antigen for the lyiiq)hocyte stimulation test. The 
organisms were grown in Friis mycoplasma broth (16,17) with acid adjusted 
swine serum instead of whole serum (18). Mycoplasmas were grown in flasks 
by shaking (50 rpm) at 37°C for 3 days in a waterbath.^ 
Membranes of M. hyopneumoniae were obtained by slight modification of 
the osmotic lysis technique of Razin (19). Briefly, cells were pelleted by 
centrifugation at 12,000 X g for 15 minutes, washed once with a large 
volume of 0.02M Tris-HCl buffer, pH 7.0. The cells were then resuspended 
in prewarmed (37°C) 2M glycerol (in 0.25M NaCl) solution and incubated 
at 37°C for 15 minutes. The cell suspension was then transferred into 
50 volumes of warm (37®C) deionized water and incubated at 37°C for 
15 minutes. The membranes were collected by centrifugation at 27,000 X g 
for 40 minutes and washed once with 0.05M NaCl-O.OlM phosphate buffer, 
pH 7.0. The cells were resuspended in diluted buffer [1/20 dilution of 
0.15M NaCl-0.05M tris (hydroxymethyl) aminomethane-0.0IM 2-mercaptoethanol, 
pH 7.4] and the protein concentration determined according to Lowry et al. 
(20) with bovine plasma proteins as the standard.^ For use in the lympho­
cyte stimulation test, M. hyopneumoniae membranes were diluted to 200 pg 
of protein/ml and stored at -70*C in 1-ml aliquots. Nonviability and 
^Aquatherm Waterbath Shaker, New Brunswick Sci. Comp., Edison, N.J. 
^Lab-Trol Chemistry Control, Dade Diagnostic Inc., Aquada, Puerto 
Rico. 
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sterility of the membrane preparations were checked by inoculating 
samples on both Friis mycoplasma agar and broth. 
Isolation of Lymphocytes 
Heparinized blood samples (20 U heparin/ml of blood) were diluted 
1:2 with phosphate buffered saline solution containing 1% glucose (PBSS-
glucose). The diluted blood was layered on a Ficoll-sodium diatrizoate 
solution (Histopaque-1077^) and centrifuged at 400 X g for 30 minutes at 
room temperature. The PEL rich band was collected and washed once with 
PBSS-glucose by centrifugation at 150 X g for 10 minutes. Contaminating 
erythrocytes were lysed by incubating the PBL in 0.83% NH^Cl-O.OM phos­
phate buffer (pH 7.2) for 5 minutes at room temperature. The PBL were 
then washed twice with PBSS-glucose. Following the final wash the PBL were 
resuspended in RPMI-1640^ medium supplemented with fetal bovine serum** 
(15%), penicillin^ (50 lU/ml), streptomycin** (50 ug/ml), kanamycin** (50 pg/ 
ml), L-glutamine (2mM) and HEPES (lOmM). The PBL were counted and the 
concentration adjusted to 2 X 10^ lymphocytes/ml. Viability as determined 
by trypan blue dye exclusion test was >98%. 
On days of necropsy, bronchial lymph nodes were aseptically collected 
and placed in Hanks' balanced salt solution without Ca-H- or Mg++** (HBSS). 
The lymph nodes were minced using a pair of forceps and a scalpel. The 
^Sigma Chemical Co., St. Louis, Mo. 
'S'low Laboratories Inc., McLean, Va. 
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cell suspension was transferred to a tube and the large pieces allowed to 
sediment. The supernate was removed and centrifuged at 150 X g for 10 
minutes at room temperature. Cells were resuspended in NH^Cl-phosphate 
buffer and incubated as above. Bronchial lymph node lymphocytes (BLNL) 
were washed twice with PBSS-glucose and resuspended in supplemented RPMl-
1640. Cell concentration was adjusted to 2 X 10^ lymphocytes/ml. 
Viability of BLNL was >90%. 
Lymphocyte Stimulation Test 
Lymphocytes were dispensed in 100-^1 volumes in the wells of micro— 
titer plates^ with equal volumes of concanavalin A type IV^ (ConA 4 pg/ml), 
phytohemagglutinin A type (PHA 10 pg/ml), pokeweed mitogen^ (PWM 5 ^g/ 
ml), heated (60 min. at 56°C) or nonheated M. hyopneumoniae cell membranes 
(4 |ig/ml) or control medium (HBSS). All cultures were set up in triplicate 
and incubated for 3 days (ConA, PHA, PWM and HBSS), or 5 days (ConA, 
M. hyopneumoniae and HBSS), at 37°C in an atmosphere of 5% CO^ in air and 
high humidity. Eighteen hours before harvesting the respective plates, 
1 pCi of [^H]-thymidine® (specific activity 6.7 Ci/mmol) was added to each 
well. The cells were collected on glass fiber paper strips^ using a cell 
harvester (Microharvester^). After air-drying, glass fiber disks were 
placed in 4 ml of scintillation cocktail [42 ml PPO-POPOP concentrate 
®New England Nuclear, Boston, Mass. 
^Bellco Glass Inc., Vineland, N.J. 
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(Liquifluor®) plus 1000 ml toluene] and [^H]-thymidine incorporation 
counted using a liquid scintillation counter.® Results were expressed as 
a stimulation index calculated as follows: SI=cpm in stimulated cultures/ 
cpm in control cultures. Because great variations were seen in cpm of 
control cultures, a SI of 3 or greater was considered positive. 
Necropsy 
Following electrocution, pigs were exsanguinated. After a piece of 
the right cardiac lobe was taken aseptically for microbiologic examination, 
lungs were removed and examined for gross lesions of MPS. The number of 
lobes with lesions was recorded and the lesions were sketched. Mean 
percentage of area of lungs with lesions was measured with an image 
analyzer 
Lung Washings 
After the gross lesions of MPS were sketched, the left bronchus was 
clamped and the left lung removed; 30 ml of phosphate buffered saline (PBS) 
were injected into the bronchus and the lung massaged for about 1 minute. 
The lung washings (LW) (5 to 10 ml) were centrifuged at 1000 X g 
for 10 minutes and the supemate stored at -70°C. Before performing 
assays to detect antibodies to M. hyopneumoniae, the LW were concentrated 
by freeze-drying and reconstituted to a 1-ml volume. 
®LS-230, Beckman Instrument Inc., Fullerton, Ca. 
^odel MOP-3, Carl Zeiss Inc., Thomwood, N.Y. 
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Hlstopathology 
Samples of lung tissue were taken from 4 lobes with lesions, when 
possible, and fixed In 10% buffered formalin. Tissues were cut at 5 um, 
processed according to standard procedures and sections stained with 
hematoxylin and eosin. Using light microscopy, the tissues were 
examined for presence of lesions characteristic of MPS (21). 
Bacteriologlc and ïfycoplasmal Cultural Procedures 
All bacteriologlc and mycoplasmal cultural procedures used were 
similar to those described by Ross et al. (22). Â piece of right cardiac 
lobe was ground in Frlis liquid medium (without added antibiotics) using 
a TenBroeck tissue grinder. Serial tenfold dilutions of the lung homo-
genate in Frlls broth with methicillin and bacitracin were carried out 
to 10 Samples of secretions from the nasal cavity, trachea, and right 
bronchus were collected with sterile cotton-tipped applicators. 
Complement-Fixation Test 
All serum samples collected and reconstituted LW were assayed for 
presence of antibodies to M. hyopneumoniae by a modified (23) direct 
mlcrotiter complement-fixation-test (CF) (24). 
Direct Immunofluorescence 
Lung samples collected contiguous to the 4 samples collected for 
hlstopathology were embedded immediately in an ethylene glycol-based 
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medium (OCT^) and frozen rapidly over dry ice. Evaluation for presence of 
M. hyopneumoniae or its antigens was done by a direct immunofluorescence 
procedure (25). 
Indirect Immunofluorescence 
Three sections per pig of frozen lung tissue and bronchial lymph node 
(BLN) collected at necropsy were cut at 6 /jm with a refrigerated micro­
tome.^ Tissue sections were fixed in acetone for 10 minutes and air-dried. 
For each pig individual lung and BLN, tissue sections were overlayed with 
50 fil of murine monoclonal antibodies raised against either swine IgM, IgG, 
or IgA and incubated for 30 minutes at 37®C in a humid chamber. Slides 
were washed twice in cold PBS for 5 minutes with agitation. Tissue sec­
tions were ovelayed with 50 pi of a fluorescein-conjugated goat anti-mouse 
IgG^ (H&L chain specific) and incubated for 30 minutes at 37"C in a humid 
chamber. Slides were rinsed twice in cold PBS for 5 minutes with agitation. 
Tissue sections were air-dried, mounted with glycerol-PBS (9:1) and kept at 
4*'C until examined. Sections of lung and BLN were examined with a binocu­
lar microscope^ equipped with a dark field condenser and an Osram HBO 200 
mercury vapor lamp. A blue excitatory filter (BG112) and a yellow barrier 
^ab-Tek Products, Division of Miles Laboratories Inc., Naperville, 
111. 
^American Optical, Buffalo, N.Y. 
^el-Freez Biologicals, Rogers, Ark. 
^Emst Leitz, Wetzler, West Germany 
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filter (K530) were used. The intensity of fluorescence was scored on a 0 
to 3+ scale (26). 
Enzyme-Linked Immunosorbent Assay 
All reconstituted LW and the corresponding serum samples collected the 
day before necropsy were assayed for identification of the immunoglobulin 
classes of antibodies to M. hyopneumoniae by an enzyme-linked immunosorbent 
assay (ELISA). Preparation of the antigen and all solutions used were the 
same as those described by Piffer et al. (27). Following adsorption of the 
antigen to the plates, these were stored at -20°C until used. On day of 
use, plates were warmed at room temperature and washed 4 times. LW or se­
rum to be tested (100 iil) were added to the wells and the plates incubated 
at 37°C for one hour. The plates were then washed 4 times and 100 ul of 
murine monoclonal anti-swine IgM, IgG, or IgA added to the appropriate 
wells. Following incubation for one hour at 37°C, plates were washed 4 
k times and 100 ul of peroxidase-labeled goat anti-mouse IgG (H&L chain spe­
cific) added to each well. Plates were incubated for one hour at 37°C. 
The plates were washed 4 times and 100 pi of substrate (5-aminosalycilic 
acid and HgOg) added. After 30 minutes, the enzymatic reaction was stopped 
by adding 20 ul of IN NaOH. Absorbance at 488 nm was measured directly in 
the microliter plate wells. 
Statistical Analysis 
Analysis of variance was used to compare the mean stimulation indices 
of the two groups. The two-sided Student t-test was used to compare mean 




Gross lesions of pneumonia were found in all M. hyopneumoniae 
inoculated pigs. Lungs of infected pigs killed at 2 and 4 WPI had lesions 
in every lobe while lungs of infected pigs killed at 6 WPI had lesions in 
all but 4 lobes (Table 1). No significant difference was found in the 
percentage of lung with pneumonia in pigs killed at 2 and 4 WPI, but a 
significant decrease in the amount of gross lesions had occurred at 6 WPI 
(Table 1). 
Upon microscopic examination, typical lesions of MPS consisting of 
peribronchial, peribronchiolar, and perivascular lymphoid hyperplasia were 
seen in every lobe obtained from infected pigs. At 6 WPI, the lymphoid 
hyperplasia appeared to be more severe around or close to bronchioles, and 
frequently lymphoid nodule formations could be seen scattered throughout 
sections of lung. 
Bacteriologic Examination 
Lung homogenates from all noninfected pigs were culture-negative for 
Bordetella bronchiseptica, Pasteurella multocida, Haemophilus spp., or 
mycoplasmas. Cultures of lung homogenates from infected pigs resulted in 
isolation of M. hyopneumoniae from all samples; lung homogenates from all 
infected pigs were culture-negative for bacteria. 
No bronchiseptica, multocida, Haemophilus spp., or other porcine 
mycoplasmas were isolated from nasal secretions, tracheal secretions or 
Table 1. Pathological and microbiological findings following experimental M. hyopneumoniue 
infection 





WPI (n=No. of pigs) 




of lung * ^  
pneumonic ' 
No. of pigs 
positive 
No. of pigs 
positive 






0/35 0 0 0 0/20 
Infected 
(n=5) 




0/35 0 0 0 0/20 
Infected 
(n=5) 




0/28 0 0 0 1/16 
Infected 
(n=4) 
24/28 2.8+2.7^ 4 4 7/16 
Groups with different superscripts differ (p<.05). 
X +SD. 
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bronchial secretions of either infected or noninfected pigs. 
Direct Fluorescent Antibody Test 
Presence of M. hyopneumoniae or its antigens was detected by direct 
fluorescent antibody (DFÂ) technique in one lobe from one noninfected pig 
and the intensity of fluorescence was low. In lung sections from infected 
pigs, the DFÂ test was positive for 70% of examined lobes from pigs killed 
2 WPI; 80% of the examined lobes from pigs killed 4 WPI; and 43% of the 
examined lobes from pigs killed 6 WPI (Table 1). 
Complement-Fixation Test 
All infected pigs had detectable CF antibody titers in their serum 
by the second week post—inoculation. The mean antibody titer increased 
over the next few weeks and remained high until the end of the experiment 
(Figure 1). 
Complement-fixing antibodies to M. hyopneumoniae were present in 
samples of lung washings collected from every infected pig killed at 2 and 
6 WPI and in 4 out of 5 pigs killed 4 WPI. 
Lymphocyte Stimulation Test 
In all instances when PBL from infected and noninfected pigs were 
stimulated with M. hyopneumoniae membranes, positive SI were obtained. 
Considerable weekly variations were noted but generally the response of 
PBL from infected pigs was higher than the one obtained with PBL from non­
infected pigs. Significant differences (p<.05) between infected and 
Figure 1. Complement-fixing antibody titer (geometric mean titers) following exposure 
to M. hyopneumoniae 
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noninfected pigs were noted at 4 and 6 WPI when nonheated membrane prep­
arations were used (Figure 2), and also at 6 WPI when heated membrane 
preparations were used, PEL from infected pigs having the higher SI 
(Figure 3). Heat-treatment of the membranes did not have a consistent 
effect on PEL from infected and noninfected pigs. On some occasions in­
creased SI were noted while on other occasions a decrease in SI had 
occurred (Figures 2 and 3). 
Nonspecific stimulation of BLNL from noninfected animals was seen at 
2 and 4 WPI but SI were low (Table 2). High SI with BLNL from infected 
pigs were obtained 2 WPI and a smaller, but still, significantly in­
creased SI (p<.01) was detected at 6 WPI (Table 2). At 4 WPI, no signi­
ficant difference between the SI obtained with BLNL from infected and 
noninfected pigs was detected. Heat-treatment of the membranes signifi­
cantly (p<.05) reduced the response of BLNL from infected pigs at 2 and 6 
WPI from 42.4 to 7.2, and from 7.3 to 2.8 respectively (Table 2). 
Weekly responses of PEL to ConA, PHA, and PWM gave mean SI ranging 
from 20 to 140. Responses of BLNL to. these mitogens were stronger, SI 
ranging almost always between 100 and 400. No significant difference was 
found between responses of infected and noninfected pigs. 
Indirect Fluorescent Antibody Test 
Small amounts of IgM- and IgA-positive cells were seen by indirect 
fluorescent antibody (IFA) technique in most lung sections from noninfec­
ted pigs killed at 2, 4, and 6 WPI. In sections of lungs from infected 
pigs killed 2 WPI, the number of IgM-positive cells was only slightly 
Figure 2. Mean stimulation Index of peripheral blood lymphocytes following exposure 
nonheated membranes of M. hyopneumonlae 
Nonheated antigen 
0-—o Noninfected 
# # Infected 
3 4 5 6 
Weeks 
Figure 3. Mean stimulation index of peripheral blood lymphocytes following exposure 
to heated membranes of M. hyopneumoniae 
Heated Antigen 
o o Non infected 
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Table 2. Effect of experimental M. hyopneumonlae Infection on responsiveness of bronchial 





























**Groups with different superscripts in each column differ (p<.01). 
^ Number of pigs per group. 
*4* —" Stimulation index: X ± SD. 
® 56*C, 60 minutes. 
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greater than in noninfected pigs, while greater numbers of IgA-positive 
cells were present, and IgG-positive cells were found in sections from all 
5 infected pigs (Table 3). At 4 WPI, IgM-positive cells were detected in 
lung sections from infected pigs in amounts almost similar to what was 
found in noninfected pigs. Greater numbers of IgA-positive cells were 
found in lung sections from infected pigs than in noninfected pigs 
(Table 3). Almost identical quantities of IgA-positive cells were de­
tected by IFA in lung sections from infected pigs killed at 2 and 4 WPI. 
Presence of IgG-positive cells noted in sections of lungs from infec­
ted pigs killed 4 WPI generally appeared to be more numerous than in sec­
tions from pigs killed 2 WPI (Figures 4 and 5). At 6 WPI, lung sections 
from infected pigs contained small numbers of IgM-positive cells, while 
IgG- and IgA-positive cells were fairly abundant (Table 3). 
At 2 and 4 WPI, examination of bronchial lymph node (BLN) by IFA did 
not reveal great differences between infected and noninfected pigs in re­
gard to total number of cells found or class of immunoglobulin-positive 
cells present, but germinal centers were seen more frequently in BLN from 
infected pigs (Figures 6 and 7). At 6 WPI, again little difference between 
infected and noninfected pigs was seen in regard to IgM- and IgA-positive 
cells, but IgG-positive cells appeared more numerous in BLN from infected 
pigs (Table 3). Germinal centers were also found frequently in these pigs. 
ELISA 
Initial testing of the LW by ELISA was done with a 1:10 dilution of 
the concentrated lungs washings. Two weeks post-inoculation specific 
Ill 
Table 3. Innminoglobulin-positive cells in lung and bronchial lymph 
node after experimental M. hyopneumoniae infection 
Tissue 
Lung Bronchial lymph 
node 
Group 
WPI (n=No. of pigs) IgM IgG IgA IgM IgG IgA 
@ 
Noninfected + 0 + ++ + ++ 
(n=5) 
Infected + + ++ 
(n=5) 




Infected + ++ 44-
(n=5) 
Noninfected ± 0 + 44- ± 44-
(n=4) 
Fluorescence in sections of lung and lymph node was graded as follows: 
0 = no positive cell, ±: rare single cell, 4-: single positive cell, 
44-: scattered areas of positive cells, 444-: many areas of numerous positive 
cells. One section of tissue per pig was examined for each isotype and 
grades were "averaged" for the number of pigs in each group. 
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Figure 5. IgG-positive cells in lung from H. hyopneumoniae 
infected pig 4 WPI. 80X 
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Figure 7. IgM-positive cells in bronchial lymph node from 
M. hyopneumoniae infected pig 2 40X 
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antibodies to H. hyopneumoniae could be detected in all LW collected from 
infected pigs. All three isotypes of immunoglobulin were found, IgG being 
the most frequent (Table 4). At 4 WPI, specific antibodies were again 
detected in LW from all infected pigs and antibodies of the three isotypes 
were found; IgG and IgA antibodies were both present in all samples. Six 
weeks post-inoculation strong reactions were observed with all three iso­
types when using LW from the four infected pigs. 
Additional dilutions of the LW from infected pigs had to be done and 
the ELISA "repeated because it was difficult to tell, especially with pigs 
killed at 4 and 6 WPI, which of the three isotypes was predominant. Two 
weeks post-inoculation, IgG antibodies predominated in LW of 3 pigs as 
detected in the 1:10 dilution of LW. In the two other pigs, one had slight­
ly higher levels of IgM antibodies while the other one had slightly higher 
levels of IgA. At 4 WPI, 4 out of 5 infected pigs had higher levels of 
IgA relative to the other two isotypes. Two of these 4 pigs also had 
moderately higher levels of IgG antibodies. The last pig had moderate levels 
of IgA compared to the other isotypes. Six weeks post-inoculation, IgA 
antibodies were predominant in 2 of the 4 infected pigs. They were also 
found in high levels in association with high levels of IgG in one pig, 
and in moderate amount in one pig that had IgG as the predominant isotype. 
IgG antibodies were found in moderate amount in two pigs, while IgM anti­
bodies were in moderate amount in one pig with high levels of IgG and IgA 
antibodies. 
Specific serum antibodies to M. hyopneumoniae were found in serum 
samples from 2 of the 5 infected pigs killed 2 WPI, one having only IgM 
Table 4. Isotype of antibodies to M. hyopneumonlae In lung washings from infected pigs 
Immunoglobulin 
^For each Immunoglobulin Isotype, each column represents results from individual pig. 
negative, +: OD,gg within 2 and 3 SD above mean OD^gg reading of lung washing from 
nonlnfected pigs, ++: OD^gg value greater than 3 SD above mean OD^gg reading of lung washing 
from nonlnfected pigs. 
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and the other IgM and IgG antibodies. At 4 WPI, antibodies to M. hyo-
pneumoniae were detected in serum samples from all infected pigs and all 
3 isotypes were found. Strong reactions to all isotypes tested were also 
obtained with serum samples from the four infected pigs killed 6 WPI. 
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DISCUSSION 
Although weekly variations were noted, the M. hyopneumoniae membrane 
preparations used in this experiment had a consistent nonspecific mitogenic 
effect for swine PBL as indicated by detection of positive SI with lympho­
cytes from noninfected pigs. Earlier reports had mentioned possible non­
specific mitogenicity associated with M. hyopneumoniae (1,3). In previous 
experiments (28), we inconsistently detected nonspecific mitogenicity for 
swine PBL when using membranes prepared with a highly passaged field iso­
late of M. hyopneumoniae (strain 1262, passage 40-42). In the present ex­
periment, membrane suspensions were prepared using a low passage of a field 
isolate (M. hyopneumoniae strain 194, passage 7) and it is possible that 
differences in concentration of mitogenic factor exist between these two 
strains. Strain differences in mitogenic activity of Mycoplasma pulmonis 
for rat lymphocytes have been documented (29). 
Specific activation of PBL seems to take place in advancing stages 
of MPS since significant differences in SI of infected and noninfected pigs 
were noted at 4 and 6 WPI when using nonheated membranes, and at 6 WPI when 
using heated membrane preparations of M. hyopneumoniae. Highly variable 
results have been obtained with lymphocyte stimulation tests using PBL from 
pigs infected with M. hyopneumoniae. Kristensen et al. (3) reported find­
ing positive stimulation of PBL one week following contact—exposure, 
whereas Adegboye (1) first detected positive SI 15 weeks after infection. 
After the initial detection, results were inconsistent in the following 
weeks. In human pneumonia caused by Mycoplasma pneumoniae sensitized PBL 
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•were generally detected within a month following onset of disease and 
persisted for several years (30,31,32,33). 
The response of BLNL to stimulation by M. hyopneumoniae membranes 
appeared to be more antigen-specific than the response of PBL. Positive 
stimulation of BLNL from noninfected pigs occurred only twice ^ en using 
heated and nozheated membrane preparations, whereas positive SI with BLNL 
from infected pigs were consistently obtained \rtien nonheated membrane prep­
arations were, used and on one occasion when heated membrane preparations 
were used. In children with recent or active infection with M. pneiimnniae, 
the response of lymphocytes from adenoid vegetations to stimulation by 
M. pneumoniae antigens was a better indicator of infection than the response 
of PBL from the same patients (34). Kristensen et al. (3) on the other 
hand found that PBL from M. hyopneumoniae infected pigs were responsive to 
stimulation by the homologous antigen whereas lymphocytes from bronchial 
lymph node were not stimulated. Significant reduction in the response of 
BLNL from infected pigs after heat-treatment of the membrane preparations 
added support to the observation made previously (29) that the principal 
antigen(s) recognized by the lymphocytes in the lymphocyte stimulation test 
is or contains protein as its major component. 
Depression of cell-mediated immunity, as indicated by loss of respon­
siveness of lymphocytes to stimulation by PEA., has been reported following 
M. hyopneumoniae infection (35) and in other mycoplasmal pneumonias (36,37, 
38,39). In the present experiment, no significant difference in responses 
of PBL and BLNL from infected and noninfected pigs to stimulation by ConÂ, 
PEA, and PHM was detected. 
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Serum samples from all 5 Infected pigs had detectable CF antibody 
titers by 2 WPI but the ELISA detected specific antibodies to M. hyopneu-
moniae in only two of these pigs. The reason for this discrepancy is 
difficult to understand because the ELISA has been found more sensitive 
than the CF for detection of antibodies in the early stages of MPS (27). 
At 4 and 6 WPI, antibodies to M. hyopneumoniae were detected by both CF 
and ELISA in serum samples from every infected pig. By ELISA, we found 
that antibodies to M. hyopneumoniae of all isotypes tested were present 
in serum from infected pigs and IgG antibodies generally gave the stron­
gest reaction. Suter et al. (9) recently reported that the antibodies to 
M. hyopneumoniae detected by ELISA in sera of infected pigs were of the 
IgG isotype only. The specificity of the monoclonal antibodies used to 
detect the various isotypes of antibodies coupled to the sensitivity of 
the ELISA would explain the differences noted between our results and 
those of Suter et al. (9). Holmgren (40) found IgG and IgA antibodies 
to M. hyopneumoniae by indirect haemagglutination. IgA antibodies have 
also been found in human sera following M. pneumoniae infection (41,42). 
A local humoral immune response to M. hyopneumoniae was detected in 
all Infected pigs either by CF, ELISA, or both. Early following inocula­
tion (2 WPI), IgG antibodies were the most frequently identified in LW. 
As the disease progressed (4 WPI) IgA gave stronger reactions in ELISA 
and IgG antibodies could still be found in LW from all infected pigs. By 
6 WPI, reactions seen by ELISA with specific IgG antibodies in LW from in­
fected pigs were stronger when compared to results at 2 and 4 WPI. Anti­
bodies of the IgM isotype were also found in LW from most infected pigs. 
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Suter et al. (9) reported steady increases of IgG and IgA antibodies 
to M. hyopneumoniae in tracheobronchial secretions up to 5 weeks post­
infection with IgG antibodies generally giving the strongest reaction. 
By 8 weeks post-infection IgA antibodies had kept increasing whereas IgG 
antibodies had decreased. Holmgren (40) reported presence of IgA and IgG 
antibodies in tracheobronchial secretions of H. hyopneumoniae infected 
pigs but questioned the production of IgG antibodies in lung tissue and 
suggested that they were transuded from the serum. Following swine in­
fluenza, Charley and Corthier (43) could not find evidence of antibody 
transfer from serum to pulmonary secretions and concluded that antibodies 
found in lungs were locally produced. 
No difference in quantity of IgM-positive cells between infected and 
noninfected pigs could be detected by IFA during the experiment. On the 
other hand, IgA-positive cells were more numerous in lung sections from 
infected pigs and IgG-positive cells were detected only in lungs from 
infected pigs. The number of IgA-positive cells in lungs of infected pigs 
did not change much between 2 and 4 WPI whereas the number of IgG-positive 
cells appeared to have increased during the same time period. Six weeks 
after inoculation the number of IgA- and IgG-positive cells were still 
high. Suter et al. (9) reported that increase of IgA- and IgG-positive 
cells had occurred 3 weeks after M. hyopneumoniae infection but by 5 WPI, 
a rapid decrease occurred. In M. pneumoniae-infected hamsters, the peri­
bronchiolar and perivascular lymphoid hyperplasia consisted mainly of IgM-
positive cells with variable amounts of IgG-positive cells and minimal 
numbers of IgA-positive cells (26). Mice infected with M. pulmonis were 
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found to have IgG as the predominant isotype of inmunoglobulin-positive 
cells in perivascular and peribronchiolar lymphoid hyperplasia (44). Ge­
netic differences in rat strains probably accounted for the fact that fol­
lowing M. pulmonis infection only IgA-positive cells increased in lungs of 
F344 rats (45,46), and IgM-, IgG-, and IgA-positive cells increased in LEW 
rat lungs (46). 
Although no great difference was found in number or class of immuno-
globulin-positive cells in BLN from infected and noninfected pigs in early 
stages of MPS, detection of more germinal centers in BLN from infected pigs 
suggests involvement of the local immune response. In later stages of the 
disease (6 WPI), IgG-positive cells were more numerous in lymph nodes from 
infected pigs than noninfected pigs. These results are consistent with 
those of Suter et al. (9). In addition, the results support the observa­
tion that, following M. hyopneumoniae infection, cell proliferation oc­
curred in germinal centers (47), as well as in paracortical areas (12,47). 
When evaluating the different immune responses developing in experi­
mentally induced MPS it seems that the local humoral immune response better 
parallels recovery from the disease. This is based on the findings that 
significant reduction in lesions of pneumonia and reduced detection of 
M. hyopneumoniae by I FA was observed when large amounts of immunoglobulin-
positive cells in lungs and strong positive reactions to M. hyopneumoniae 
in ELISA with LW were detected. Increasing intensity of IgG antibodies in 
ELISA and greater numbers of IgG—positive cells would suggest a more active 
role for this immunoglobulin class, even though IgA antibodies are also 
fairly abundant. In the porcine respiratory tract, IgG antibodies and 
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antibody-producing cells have generally been associated with the lower 
respiratory tract, while IgA are predominant in the upper respiratory 
tract (48,49). Studies on M. pulmonis infection in mice have indicated 
that IgM, IgG, or IgA could mediate resistance to infection with this 
mycoplasma (50). 
Cell-mediated immunity, as detected by the lymphocyte stimulation 
test, was noticed early post-inoculation with BLNL and later on with PEL. 
It is possible that sensitization of local lymphocytes occurs soon after 
inoculation and that sensitized lymphocytes will reach the systemic cir­
culation after a certain time. Detection of stronger stimulation to 
M. pneumoniae with PBL from older patients suggested that repeated asymp­
tomatic infection resulted in increasing numbers of sensitized lymphocytes 
reaching the systemic circulation (51). 
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A characteristic common to various mycoplasmal pneumonias is the 
nature of the microscopic lesions observed in lungs from infected animals. 
Peribronchiolar and perivascular lymphoid hyperplasia are typical lesions 
found following infection with M. hyopneumoniae in pigs, M. pulmonis in 
rats and mice, and M. pneumoniae in humans (36). Perivascular and peri­
bronchiolar cuffing has also been observed in gnotobiotic calves inocula­
ted with M. bovis (139) and Ureaplasma spp. (140), as well as in colos­
trum-deprived, specific-pathogen-free lambs inoculated with M. ovi-
pneumoniae (141). 
Because of the major involvement of lymphocytes in the microscopic 
lesions of MPS investigations were undertaken to evaluate various respon­
ses of lymphocytes from swine exposed to M. hyopneumoniae. Some of the 
responses, such as antibody production and cell proliferation following 
stimulation by mitogen or antigen, can give information as to the func­
tional activity of the lymphocytes. Additionally, visualization of lym­
phocytes in lung sections of pigs inoculated with M. hyopneumoniae mem­
branes and identification of some of the lymphocytes by immunofluores­
cence provide further evidences as to the interactions between M. hyo­
pneumoniae and the porcine immune system. 
Investigations into nonspecific mitogenic factors associated with 
M. hyopneumoniae indicated that membrane preparations of this organism 
stimulated PBL from conventionally-reared pigs sporadically (142), whereas 
PEL from CDCD pigs exhibited positive stimulation in all but one instance 
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vrtien tested (143). Prior to these reports, nonspecific stimulation of 
swine lymphocytes by M. hyopnetmoniae was suspected on only two occasions 
(14,15). 
The relevance of the mitogenic activity of membranes for swine 
lymphocytes in the pathogenesis of MPS can probably be better appreciated 
if we consider the fact that membrane preparations induced microscopic 
lesions of pneumonia resembling those of MPS when given IT to pigs (142, 
1^3). Although an association has been established between mitogenicity 
and lesion inducing potential for M. pulmonis in rats (63), the exact 
significance of this association in the pathogenesis of the disease is 
still not completely resolved. 
Antigen-specific interactions between antigens and the immune system 
of exposed animals can involve a humoral response, a cell-mediated re­
sponse or sometimes both. In most mycoplasmal infections, antigen-
specific interactions are generally evaluated on the basis of antibody 
levels in serum. Also, antigen-specific CMI following respiratory myco­
plasmal Infection is reported for M. pneumoniae (113,114,115,116,117, 
118) and M. hyopneumoniae (13,14,15). These specific responses were 
generally observed with PBL and on one occasion with adenoid vegetations 
following M. pneumoniae infection (117). In the present studies, speci­
fic interactions between the porcine immune system and M. hyopneumoniae 
Involved mainly the lymphocytes from bronchial lymph nodes (142,143,144) 
and antibodies present in lung secretions as well as in serum (144). 
At this point, a hypothesis as to the possible role of M. hyo­
pneumoniae in the pathogenesis of MPS can be put forward. It is possible 
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that membranes, and most probably live organisms, nonspeciflcally 
stimulate lymphocytes present in the lungs. Stimulated lymphocytes 
could start multiplying and/or releasing lymphokines that would attract 
other lymphocytes to the site. With lymphocytes accumulating in the 
lungs, microscopic lesions of, or resembling those of MPS should be 
detectable after 5 to 7 days based on the results of the lymphocyte stimu­
lation test (142,143). This interval is within the time frame of detec­
tion of microscopic lesions in lungs of pigs receiving M. hyopneumoniae 
membranes (142,143) and also of lesion development in natural or experi­
mental infection (132). If the stimulation of lymphocytes is allowed to 
persist, as in the case of experimental infection (144), appropriate 
clone(s) of B-lymphocytes could be triggered to produce specific anti­
bodies that would eventually result in control of the infection. This 
scheme would be consistent with our observations that severity of micro­
scopic lesions of MPS was reduced by previous exposure to M. hyopneumoniae 
membranes (142), and that recovering stages of MPS are associated with in­
creasing development of the local humoral response (144)• 
The results additionally suggest that specific antigen recognized 
by BLNL of sensitized animals would be different from the nonspecific 
mitogenic factor stimulating lymphocytes. This is based on the observa­
tions that heat treatment of membranes used in lymphocyte stimulation 
test generally reduced the SI of BLNL from membrane-inoculated or M. 
hyopneumoniae-infected pigs whereas the response of BLNL from control 
pigs was not affected by heating the membranes. Heat resistance would 
suggest that the mitogenic factor associated with M. hyopneumoniae is 
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not constituted primarily of protein, such as those associated with M. 
pulmonis (56) and probably M. arthritidis (53,54). This would leave 
carbohydrates and/or lipids as possible constituent(s) of the mitogenic 
factor. The mitogenic factor of M. neurolyticum is composed mainly of 
carbohydrates with possible involvement also of lipids and proteins (47). 
Additional information on the interactions between M. hyopneumoniae 
and the porcine immune system is needed to fully understand the patho­
genesis of MPS. Difference observed in response of lymphocytes to 
stimulation by membranes from high passage field strain (142) and low 
passage field strain (144) might indicate variations in concentration or 
potency of mitogenic factor between strains. Also, difference noted in 
susceptibility of lymphocytes from conventionally-reared and CDCD pigs to 
stimulation by M. hyopneumoniae membranes would warrant further investi­
gations into determining which lymphocyte subpopulations are primarily 
stimulated by the membranes. 
Although numerous areas concerning the pathogenesis of MPS still 
need clarification it seems that based on the information gathered in 
the different experiments of this study, induction of an efficient local 
immune response as a method of control of MPS has to be attempted. 
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